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ABSTRACT 
 
ROBERT STEPHEN BOWEN. The role of the sex steroids in regulation of physical 
activity levels in mice. (Under the direction of DR. J. TIMOTHY LIGHTFOOT) 
 
 
 Low physical activity (PA) levels are associated with many chronic diseases and 
place a massive burden on the health care system.  The extrinsic environment has been 
suggested to regulate activity levels, but an increasing prevalence of physical inactivity in 
developed societies suggests the presence of other regulating factors.  The sex steroids 
affect PA levels, but the regulating mechanisms are not known.  The purpose of this 
study was to evaluate the interrelationship of sex steroids and PA in mice and the 
involvement of dopamine 1 receptors (Drd1) in sex steroid regulation of PA.  First, sex 
steroid levels were manipulated in male and female mice by gonadectomy and 
replacement via silastic implants.  Wheel running decreased in both sexes after removal 
of the gonads.  Testosterone administration to gonadectomized mice completely reversed 
the PA deficit while administration of 17β-estradiol recovered 50% of the deficit.  Next, 
the aromatase complex was pharmacologically inhibited.  Wheel running levels remained 
unchanged in normal, orchidectomized, and steroid replaced male mice suggesting the 
presence of an androgen responsive PA regulating mechanism.  Finally, PA levels were 
observed after orchidectomy in mice receiving either testosterone or a Drd1 antagonist.  
PA levels were elevated by testosterone, but were unaffected by the antagonist.  The 
levels of Drd1 mRNA in the nucleus acumbens and striatum were evaluated after 
administration of these two compounds.  Drd1 mRNA expression was not different 
between treatments or compared to control mice.  These results suggest that PA is 
regulated by the estrogens and androgens, but the influence is not regulated by Drd1. 
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INTRODUCTION 
 
 
 Physical inactivity is associated with decreased health and excessive health care 
burdens in developed societies.  Increasing physical activity can have profound effects on 
quality of life and certain diseases including obesity (150), cardiovascular disease (33), 
certain types of cancers (132), and diabetes (148).  Physical activity levels are 
significantly regulated by genetic and biological (non-genetic) mechanisms (83).  The sex 
steroids represent potential biological modulators of activity and have been shown to alter 
the activity patterns of rodents (81).  After surgical removal of the gonads, rodents exhibit 
very low levels of activity (6, 7, 15, 22, 43, 54-56, 107, 108, 110, 111, 114, 141, 143, 
144, 151).  The surgically induced activity deficit is reversed by administration of both 
testosterone and 17β-estradiol (6, 7, 15, 43, 55, 107, 108, 110, 114, 144, 151). 
 Compounds released from ovarian and testicular tissue are known to influence 
behavioral, physiological, and anatomical characteristics.  Physical activity, as quantified 
by wheel running in rodents, has been studied as a behavioral characteristic for over a 
century (129).  As early as the 1920s, it was known that physical activity was 
dramatically affected by the sex steroids.  In 1923, Wang (141) first observed a cyclical 
relationship between activity levels and the vaginal content of female rats.  In 1924, 
Slonaker (121) confirm the involvement of the reproductive tract through the study of 
activity patterns during periods of significant reproductive changes in female rats.  Then 
in 1925, Hitchcock (52) observed significant differences in the wheel running activity 
between the sexes noting a higher propensity for locomotion in female rats.  These 
observations suggested the involvement of a compound(s) that was related to sexual 
gland physiology in females.  In order to isolate the tissues and/or compound(s) involved 
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in the phenomenon several research efforts were undertaken using various isolation and 
preparation techniques (15, 22, 107, 108, 120, 142, 143).  In brief, removing the ovaries 
reduced the activity drive.  The drive was recoverable; however, with the administration 
of whole ovarian tissue  extracts (22), reproductive related fluids including urine from 
pregnant rodents (107), and crude extracts of amniotin and oestrin, early estrogen 
containing compounds (108).  Interestingly, changes in ovarian steroid concentrations 
were not limited to females.  Wang et al. (144) found increased wheel running in male 
rats surgically grafted with the ovaries of female littermates. 
 More recent studies have confirmed previous research with more precise 
conditions, delivery techniques, and steroidal preparations (43, 72).  Using specific 
estrogen receptor knockout mice, Ogawa et al. (92) demonstrated a clear involvement of 
the alpha isoform of the estrogen receptor (ERα) in activity regulation.  Testosterone was 
suggested to act on activity in rats through estrogen dependent means (114); however 
observations (results presented in Chapter 2) indicate the presence of multi-faceted 
(androgenic and estrogenic) effects regulating activity.  The remaining mechanistic steps, 
from the molecular and cellular pathways initiated by the ERα to the outward expression 
of the physical activity phenotype, are yet to be understood. 
 Despite the differences in activity patterns noted between the sexes by Hitchcock 
(52), several studies investigated the effects of the male sexual glands on activity levels.  
In 1925, Hoskins (54) noted elevated activity levels in male rats with normal functioning 
sex organs compared to castrated littermates.  In attempts to recover the induced activity 
deficit, Hoskins (55) grafted testicular tissue into subcutaneous pockets over the 
abdominal muscles.  The grafting technique did not lead to noticeable deviations in 
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activity levels in the castrated rat.  The affinity of the grafting techniques used to 
reintroduce testicular tissue were subsequently reanalyzed (110).  Richter and Wislocki 
(110), in 1928, found a correlation between successful testicular grafting surgeries 
(notable remnants of implanted tissue) and the activity levels of castrated male and 
female rats. 
 As previously discussed, the androgenic effects on activity are hypothesized to be 
estrogen dependent.  Roy and Wade (114) observed increased activity when estradiol 
benzoate or aromatizable testosterone propionate were administered to castrated male 
rats.  A similar response was not noted with the administration of non-aromatizable 
dihydrotestosterone propionate.  The stimulatory effects of estradiol benzoate and 
testosterone propionate were notably inhibited via MER-25 administration, an estrogen 
antagonist (114). 
 The regulation of physical activity may involve not only estrogenic and/or 
androgenic compounds.  These compounds likely interact with sex steroid receptors 
leading to activation of downstream factors (81).  The specific compound(s) involved in 
the downstream actions of the sex steroids are yet to be fully determined.  Of 
noteworthiness, however, are dopamine and the dopaminergic system.  Previous studies 
have not only shown interaction between the sex steroids and the brain (48, 50), but 
recent research (70) has also shown differential expression of dopamine receptors 
between high and low active mice.  Specifically, the dopamine 1 receptor expression was 
shown to be lower in high active mice (C57L/J) compared to low activity mice 
(C3H/HeJ).  Further, in pharmacological studies using a D1-like antagonist in our lab, 
activity levels in C57BL/6J mice were significantly increased above baseline (A. M. 
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Knab, personal communication).  The interaction between the sex steroids and 
dopaminergic system within the striatum and nucleus acumbens has previously been 
examined (9).  Becker (9) found changes in dopamine activity following ovariectomy and 
during the cyclical pattern of the estrous cycle in female rats.  The interaction is 
suggested to influence addiction susceptibility to psychomotor stimulants and increases 
pacing behavior in rats (9). 
 Currently, there are no studies investigating how the aromatase complex, sex 
steroids, and downstream factors interact to regulate activity.  In the following chapters, 
these facets will be investigated.  Chapter 1 contains an extensive review of both rodent 
and human literature focused on physical activity regulation via the sex steroids.  
Currently, the human portion of this chapter has been conditionally accepted to the 
journal Sports Medicine.  In Chapter 2, the effects of gonadectomy and steroid 
replacement were evaluated in both male and female C57BL/6J mice.  It was observed 
that activity was greatly reduced in both sexes after gonadectomy and testosterone 
recovered activity more efficiently than 17β-estradiol in both sexes despite the steroids 
being reintroduced in equal amounts.  This chapter is in preparation for review in 
Physiology and Behavior.  Chapter 3 evaluated the involvement of the aromatase 
complex in regulating activity levels in male mice using pharmacological inhibition.  
Activity levels were not altered in intact or orchidectomized mice nor enhanced by 
steroid supplementation or replacement strategies.  This chapter is in preparation for 
review in Endocrinology.  Lastly, Chapter 4 investigated the interplay between the sex 
steroids and the dopaminergic system.  Wheel running was inhibited via orchidectomy 
and recovery from the induced deficit was attempted through administration of 
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testosterone and a dopamine 1 receptor antagonist (SCH23390).  Testosterone 
significantly increased wheel running activity, however, the antagonist failed to resolve 
the deficit.  Striatum and nucleus acumbens dopamine 1 receptor mRNA and protein 
levels were not found to vary in mice receiving testosterone treatment suggesting that the 
sex steroids’ effects are not transmitted through dopamine 1 receptors in these brain 
regions.  This chapter is also being prepared for review in Physiology and Behavior. 
 This dissertation represents a concrete basis for future studies involving rodents 
and human subjects.  The evidence gathered by this study suggests that activity is 
regulated by testosterone and other androgenic molecules in mature male mice.  
Furthermore, although the brain is a likely physical activity center, the dopaminergic 
system does not appear to relay testosterone’s effects on activity levels.  In the future, 
research will need to focus on other factors that are potentially involved in relaying the 
effects of the sex steroids on physical activity levels. 
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CHAPTER 1: LITERATURE REVIEW 
ARE THE SEX STEROIDS INVOLVED IN THE REGULATION OF PHYSICAL 
ACTIVITY LEVELS IN RODENTS OR HUMANS? 
 
 
Introduction 
 It has become axiomatic that the daily accumulation of physical activity will 
offset many different health conditions and will lead to increased quality and quantity of 
life (138).  However, there are stark differences in the amount of regular physical activity 
that human males and females complete with little scientific explanation for these 
differences.  While the regulation of physical activity has long been thought of as 
voluntary and/or influenced solely by environmental factors, there is a growing body of 
evidence that suggests that physical activity, as defined as any movement requiring the 
expenditure of energy including tasks of daily living and planned exercise, is at least 
partially regulated by biological factors (28, 63, 64, 76, 79, 82, 83, 97, 130, 131, 136).  
These biological regulating factors may take many forms including an increase or 
decrease of various physiological substance or structures, and/or genetics which may 
fundamentally alter receptor/protein interaction in the intact organism (82, 83, 130).  The 
extensive animal literature has shown that sex of the individual significantly influences 
physical activity patterns by working through various sex-related hormonal pathways 
(81).  Biologically, sex steroids play a large role in regulating various physiological 
parameters; thus, they have naturally been the subjects of investigations trying to 
elucidate the possible roles they play in regulating physical activity in animals.  At this
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point, the role that sex steroids play in regulating human activity has been largely 
unexplored, probably due to the unappreciated role that biological factors play in 
regulating ‘voluntary’ activity.  The increasing rate of cardiovascular and other 
hypokinetic diseases in women (31) and the strong association between low physical 
activity levels and all cause mortality in the developed world (87) make understanding 
the mechanisms regulating physical activity critical in the context of the health-related 
goals of our society.  The focus of this chapter is to review the literature investigating the 
effect of and the possible physiological mechanisms through which the various sex 
steroids regulate physical activity.  Both the rodent and human literature will be 
considered in this review. 
 For the purpose of this review, physical activity level in rodents will be based 
primarily on wheel running indices (revolutions, distance, duration, speed) or in a few 
cases breakage of infrared beams in in-home cage type studies.  In the human literature, 
physical activity will be considered the total amount of activity an individual 
accomplishes in the course of a day which not only includes formal exercise, but 
movement that is associated with activities of daily living (e.g. stair climbing, yard work, 
gardening, etc.).  This operational definition includes estimates of physical activity level 
based on energy expenditure levels that are corrected for body mass.  Whereas males of 
most species generally have larger masses than females, presenting energy expenditure 
data as physical activity levels without correcting for mass biases the estimates toward 
males regardless of total daily activity. 
Brief Overview of the Biochemistry of Sex Steroids 
 The biochemistry of sex steroid steroids is well understood and summarized in 
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Figure 1.  Sex steroids primarily consist of androgens (testosterone) and estrogens (17β-
estradiol).  Both are primarily derived from progestins (progesterone) via 
dehydroepiandrosterone, androstenedione, and androstenediol, which are formed from 
cholesterol and pregnenolone upon stimulation by adrenocorticotropic hormone (ACTH).  
While the primary sex steroids differ between males (testosterone) and females (estrogen) 
as do the primary sites of synthesis (testes – male; ovaries – female), quantities of 
testosterone and estrogen occur in both sexes.  Testosterone is also an intermediate 
substance in the formation of estrogen in both males and females.  Through an 
aromatization process using the aromatase (Cyp19) enzyme complex, testosterone is 
converted to 17β-estradiol; this conversion is not reversible.  In males, while some 
testosterone is converted to estrogen, the majority of testosterone is converted into 
dihydrotestosterone, which cannot be aromatized into estrogen.  While testosterone 
concentration exhibits minor variations on a daily basis in healthy, adult males (≈6-10 
ng·ml-1), estrogen and progesterone exhibit cyclical peaks in females, with estrogen 
peaking at approximately 200-300 pg·ml-1 at day 12 of the menstrual cycle (during the 
follicular phase) then drops to approximately 100-150 pg·ml-1 during the early luteal/late 
follicular transition.  A progesterone peak of 8-10 ng·ml-1 occurs at approximately day 20 
of the cycle and is coupled with a concurrent rise in estrogen to approximately 150-200 
pg·ml-1 (during the luteal phase).  The hormonal fluctuations evident in females are 
characteristic of healthy, adult females and are not typically seen in pre-pubescent girls or 
menopausal women. 
Are Physical Activity Patterns Regulated by the Estrogens in Rodents? 
 The sex steroids have long been known to influence behavioral and physiological 
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characteristics of animals.  Berthold (10) found extensive differences in adult roosters’ 
comb and wattle morphology after the removal of their testicles while still chicks.  The 
researchers observed behavioral and interactive differences; the individuals with the 
smallest combs and wattles were suppressed to the lowest ranks in the pecking order and 
were overly subordinate.  The presence of certain chemicals emitted from the testes of the 
roosters was important in the listed behavioral and morphological characteristics.  The 
presence of such chemicals originating in the sexual organs of animals could be related to 
a large number of behavioral and morphological characteristics given the proper ability to 
measure and quantify a behavior of interest. 
 Sexually Dimorphic Wheel Running:  In the first part of the 20th century an 
apparatus to measure and record wheel running behaviors in small rodents was devised 
(119, 129) and used initially to evaluate activity in response to environmental variables 
(129) and during aging (122, 123).  It was observed during these studies that activity 
differences existed between the sexes.  Female rats tended to be more active than male 
rats (122).  The presence of sexually dimorphic activity patterns were also observed by 
Hitchcock (52) using running wheels.  Females ran consistently more than males and 
interestingly both sexes displayed seasonal variation in activity (52).  The observations of 
a sexually dimorphic activity pattern made by Slonaker (122) and Hitchcock (52) 
supported the idea that activity was regulated, in part, by the sexual glands of rodents. 
 Wheel Running across the Estrous Cycle:  Comprehensive descriptions of the 
estrous cycle in the white rat by Long and Evans (84) and the activity pattern—originally 
suggested to be hunger induced—by Richter (105) allowed for more formal study of 
activity regulation via the sexual glands in females.  Wang (141, 142) under the direct 
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mentorship of Richter evaluated the vaginal secretions of female white rats using the 
techniques conveyed by Long and Evans (84) and correlated the smear content of the 
secretions with the activity measured during daily exposure to a wheel running cage.  
Wang observed well-defined and consistent peaks in activity when cornified epithelial 
cells (estrous phase) were present alone in the vaginal smear.  During this phase, the 
female rat ran nearly 4,000 revolutions on the running wheel, nearly twice as many 
revolutions compared to the other phases of the cycle.  Based on these seminal studies, it 
was concluded that the activity pattern in female rats was inherently associated with the 
function of the ovaries and was stimulated at the onset of the estrous cycle. 
 Effects of Reproductive Condition on Physical Activity:  The female rat undergoes 
several life changes in which the estrous cycle is altered.  Prior to puberty, the estrous 
cycle is not present.  At puberty estrous begins and develops throughout adolescence.  In 
the middle of life, this cycle is consistent and remains naturally uninterrupted until 
menopause.  The presence of the estrous cycle during middle life can be artificially 
altered by several interactions including copulation, pregnancy, and pseudo-pregnancy 
induced via cervical stimulation.  These interactions and at the onset of menopause 
reduce the variation of the estrous cycle considerably.  The relationship between activity 
levels and these natural and artificial life conditions provides a unique opportunity to 
investigate how the two factors are related. 
 The activity of rats prior to puberty is very low and vigorously changes at the 
onset of puberty (121, 141, 142).  Slonaker (121) observed several female rats during the 
puberty transition and observed an increase in wheel running from zero to greater than 
20,000 revolutions in the middle of life.  Wang (141) showed similar results at the onset 
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of puberty; however, the development of a cyclical pattern took a longer period of time, 
an effect potentially associated with lower levels of interactions (lack of vaginal smear 
collections) compared to Slonaker’s (121) study.  The additional stress induced by the 
collection technique may stimulate the process, thereby forcing accelerated development 
of a consistent estrous cycle. 
 After the onset of puberty, the activity pattern of the rats was elevated but 
remained variable (120, 121, 141, 142).  Activity peaks typically developed every fourth 
day in a manner consistent with the presence of cornified epithelial cells during the 
estrous phase of the estrous cycle.  Wang (141, 142) and Slonaker (120, 121) consistently 
observed wheel running levels between 4,000 and 40,000 revolutions, or about 6 to 50 
km per 24 hour time period when the wheel’s circumference is taken into account. 
 The elevated levels of wheel running observed throughout midlife remain 
consistent unless the estrous cycle is disrupted.  Slonaker (120) found distinct alterations 
to the running pattern throughout the processes of copulation and pregnancy.  Upon 
successful mating, the female rat reduced wheel running activity from about 8,000 
revolutions per day to about 3,000 revolutions per day (120).  This effect was consistent 
throughout the entire gestational period.  At arrival of the litter, the wheel activity further 
reduced to about 1,500 revolutions per day, remaining low throughout the lactation 
period.  After weaning the pups, Slonaker (120) noted a substantial increase in wheel 
running activity within five to seven days.  The decrease in activity observed after 
copulation could be mimicked by manual stimulation of the cervix, inducing pseudo-
pregnancy.  The activity levels during pseudo-pregnancy were similar to the levels 
observed during gestation (120).  In most cases, the activity pattern returned to normal 
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within fifteen days and coincided with the reoccurrence of a normal, fluctuating estrous 
pattern (120).  Interestingly, in 2002, Girard et al. (40) observed similar levels of wheel 
running between control mice and mice artificially selected for high wheel running 
activity immediately following parturition.  The effect was concluded to be genetically 
independent of the wheel running phenotype (40).  Speculatively, the decreased amount 
of estrogen during pregnancy and following parturition may be overriding the genetic 
drive, established via artificial selection, for activity in these animals. 
 The end of life induces another series of changes to the estrous cycle in the female 
rat.  Slonaker (121) evaluated the estrous cycle and activity pattern of aged rats and noted 
a lengthening of the time between estrous peaks that coincided with a lengthening of the 
time between activity peaks.  Furthermore, as menopause progressed to an absence of 
cyclicity, Slonaker (121) noted a reversion of activity to very low levels which persisted 
to the end of natural life.  The use of natural breaks in the estrous cycle from pregnancy, 
onset of puberty, and development of menopause provided beneficial insight into the 
interaction between the estrous patterns and activity patterns of female rats, however, a 
more stringent control of the estrous pattern could be used to better define the 
relationship between the two patterns. 
 Effects of Ovariectomy on Physical Activity:  The added level of estrous cycle 
control was achieved experimentally through surgical removal of the ovaries (2, 6, 7, 15, 
22, 23, 43, 107-109, 128, 141, 142, 151), surgical traumatization (143), or chemical 
blockade of ovarian function (57).  Upon manipulation of the ovaries, activity has 
consistently been shown to decrease in both rats and mice.  The effects of ovariectomy, 
traumatization, and chemical gonadectomy are displayed in Table 1. 
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 The effect of gonadectomy is relative consistent across published studies, with the 
exception of Asdell et al. (6).  The researchers observed an increase in activity after 
gonadectomy; however, this data is problematic on two accounts.  First, Asdell et al. (7) 
corrected the previously published paper suggesting an inability to repeat all aspects of 
the original project.  Second, the increase in wheel running was observed between a 
single control and a single ovariectomized animal.  The general observations made by 
Asdell et al. (6) could be skewed due to this extremely low and non-statistically 
computable sample.  If these data are considered outliers, it becomes very apparent that 
the surgical removal of the ovaries from either rats or mice results in a great reduction in 
activity vigor. 
 The other strategies used, ovarian traumatization (143) and chemical 
gonadectomy (57), elicited similar responses to full surgical ovariectomy, but wheel 
running in these animals was not permanently reduced.  After a matter of weeks, wheel 
running returned to normal, pre-interventional levels.  This return of function indicates 
that unless complete removal of the tissue is preformed, the ovaries recover the ability to 
produce activity-regulating substances.  As research progressed, several chemicals 
originating in the ovarian tissue were discovered and purified and researchers adopted 
replacement strategies to evaluate the effects of different compounds on recovering 
general activity in both normal and ovariectomized rodents. 
 Effects of Replacement Strategies on Physical Activity:  During the early parts of 
the 20th century, clinicians utilized ovarian extracts to alleviate reproductive and sexual 
disorders in humans.  Durrant (22) fed ovariectomized rats glycerine extracts containing 
ground remnants of porcine ovaries, but did not observe a change in activity levels.  It 
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was speculated that oral administration of extracts was an inadequate delivery method 
because the digestive process altered the function of the not yet discovered hormone that 
was expected to cause the observed effects on activity (22).  The digestive issues were 
circumvented by Bugbee and Simon (15) by subcutaneously injecting ovarian follicular 
fluid to ovariectomized female rats.  This technique elicited positive results.  Wheel 
running was reinvigorated in the ovariectomized rat to levels observed prior to the 
ovariectomy surgery (15).  When injections were ceased, activity reverted to the lower 
levels observed after the ovariectomy surgery (15).  In contradiction to the digestive 
issues suggested by Durrant (22), Richter (107) found large and maintainable changes in 
activity when ovariectomized rats were fed urine from pregnant human females.  The 
extracts and solutions administered in these initial investigations supported the existence 
of an ovarian hormone regulating the activity patterns of rodents, but lacked the 
necessary specificity to identify the compound(s) responsible of this effect. 
 In 1933 and 1934, E.R. Squibbs and Sons developed a technique to produce 
substantial quantities of an impure form of estrogens (oestrin, amniotin), allowing for a 
higher level of identification specificity (108).  Richter and Hartman (108) injected 
ovariectomized rats with this compound and observed wheel running levels equal to the 
activity levels of control animals.  As purification technology advanced and based on the 
previous research involving administration of ovarian extracts, urines, and amniotin, it 
became clear that the compounds affecting physical activity patterns were estrogens and 
estrogenic metabolites (151).  Several other studies have administered pure forms of 
estrogens to confirm this assertion (2, 6, 19, 42, 43, 89, 90, 127, 151).   
 These effects are also existent in males.  Wang et al. (144) transplanted ovaries 
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from mature female rats to castrated male rats and observed a reinvigoration of activity in 
the inactive castrated rats.  The effect was not completely consistent, but was observed to 
be primarily related to a propensity of some rats to reabsorb the implants; the presence of 
an ovarian implant in an unabsorbed form was essential to observe changes to the activity 
pattern of the male rat (144).  The estrogens elicited changes to the activity pattern in 
rodents, but the mechanisms by which such effects were propagated remained enigmatic. 
 Potential Mechanism of Effect:  The majority of mechanistic studies regarding the 
estrogenic control of activity have focused on central factors.  Some general effects of 
estrogen on brain physiology and neuron morphology have been documented (9, 37, 48, 
50, 51, 58, 59, 75) and provide ample evidence that estrogens may be modulating their 
effects via the brain.  Becker (9) found sex differences in dopaminergic neurons in the 
nucleus acumbens and striatum of rats, an area in the brain that has been suggested to 
influence wheel running activity via alteration to the dopamine system (70). 
 The anterior hypothalamic and medial pre-optic areas of the brain are also highly 
responsive to estradiol treatment.  Hill et al. (50) observed apoptotic degradation of 
dopaminergic neurons in these regions of the brain during ovariectomy-induced estrogen 
deficiency.  More recently, the medial pre-optic area in mice has been shown to contain 
estrogen responsive, sexually dimorphic cells (51).  These brain regions, thus, are 
potential regulators of physical activity.  Fahrbach et al. (26) cannulated several rats and 
delivered a mixture of estradiol and cholesterol at various concentrations to these brain 
regions and noted four to seven fold increases in wheel running relative to rats treated 
with cholesterol alone. 
 The estrogens’ abilities to induce physiological changes in an organism are 
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directly relayed via anti-oxidant properties (88) or indirectly relayed through several 
receptors (73).  Gorzek et al. (43) evaluated the effects of tamoxifen, an estrogen 
analogue that lacks the anti-oxidant properties of natural estrogens, on physical activity in 
mice.  Tamoxifen’s ability to reinvigorate wheel running activity in ovariectomized mice 
was equal to 17β-estradiol’s ability (43); therefore, the authors concluded that the 
physiological changes in wheel running were likely due to estrogen’s interaction with 
either isoform of the estrogen receptor.  Estrogen receptor α (ERα) and β (ERβ) have 
similar distributions in the brain and near identical affinities for 17β-estradiol, estrone, 
and estriol, the three main physiologically relevant estrogens (73, 74). 
 The direct manipulation of the estrogen receptors is difficult.  To circumvent this 
barrier, phytoestrogens with substantially different receptor binding affinities and 
receptor specific knockout mice have been used to evaluate the ability of each receptor 
isoform to modulate the activity response.  Genistein, a phytoestrogen found in soy-based 
products, has a seven-fold higher affinity for ERβ than ERα (73).  Flynn et al. (30) 
provided reproductively intact male and female Sprague-Dawley rats (63-77 days old) 
genistein (0, 25, 250, or 1250 ppm) via standard rodent chow and noted no significant 
difference in wheel running activity.  Slikker et al. (118) observed similar results in  140 
day old Sprague-Dawley rats.  The presence of  normal functioning gonads in the rats 
used by Flynn et al. (30) and Slikker et al. (118), could have provided a substantial source 
of estrogens and masked any effect the genistein had on the wheel running response.  
Garey et al. (36) evaluated the effects of the phytoestrogen coumestrol (affinity: ERβ > 
ERα, ref. 73) on wheel running in ovariectomized Swiss-Webster mice.  The mice 
provided coumestrol alone did not run significantly more than control mice, but ran far 
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less than the mice that received estradiol benzoate (36).  Hertrampf et al. (45) provided an 
isoflavone rich diet (genistein and daidzein) to ovariectomized rats and found no effect 
on wheel running.  The binding affinity differences of phytoestrogens (higher propensity 
for ERβ than ERα) suggest that wheel running is not directed via the ERβ pathway. 
 Ogawa et al. (92) gonadectomized ERα and ERβ knockout mice and administered 
estradiol benzoate pellets.  The mice that retained the gene for ERα (the ERβ knockout 
mice) responded to the estradiol treatment in a similar fashion to gonadectomized wild-
type mice.  The mice lacking the ERα gene (the ERα knockout mice) exhibited low 
physical activity levels (92) suggesting that ERα is a primary regulator of activity. 
 Despite a long legacy of research regarding estrogen-induced activity regulation, 
the physiological pathways responsible for this regulation, from synthesis of estrogens to 
the alteration of brain regions, remains incomplete. 
Are Physical Activity Patterns Regulated by the Androgens in Rodents? 
 The number of studies devoted to the effect of testosterone and other androgenic 
molecules on physical activity are several magnitudes less than the literature focusing on 
estrogenic mechanisms.  Despite these vast differences in quantity of available sources, 
the role of androgens in regulating physical activity also present a long and varied history 
of scientific discourse.  In addition, the presence of sexual dimorphisms in physical 
activity patterns in adult humans, with males being more active than females (134), 
requires further discussion of the subject. 
 Effects of Orchidectomy and Replacement on Physical Activity Patterns:  In 
rodents, females of a mouse or rat strain tend to run farther than male counterparts (see 
Sexually Dimorphic Wheel Running section); however, the removal of the testes of male 
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rodents leads to significant degradations in the wheel running response (20, 34, 35, 54, 
56, 106).  The effects of castration and orchidectomy are shown in Table 2.  Much like 
the literature with female rodents, several androgenic replacement strategies have been 
utilized in orchidectomized rodents in attempts to reinstate the deficient wheel running 
behavior. 
 Hoskins (55) provided both castrated and senile rats grafts of testicular tissue 
from donor animals.  Neither group of rats had altered levels of activity.  Upon further 
investigation of the grafts, a high level of necrosis was noted rendering the grafts non-
productive.  Richter and Wislocki (110) formulated a second study using testicular grafts 
under more stringent surgical controls.  In this experiment, several grafting surgeries 
were successful and these animals—deemed “takers”—were evaluated for wheel running.  
Both male and female rats were successfully transplanted with grafts and displayed 
increased wheel running activity, but rats that received ovarian tissue responded more 
vigorously compared to testicular graft recipients (110).  The successful implantation, 
even under stringent conditions was still very limited and resulted in a low percentage (10 
to 30%) of the total attempted surgeries being successful (110). 
 Asdell et al. (6) and Jakubcazak (60) administered testosterone in a purified form 
and successfully avoided the issues associated with the grafting techniques used 
previously.  Asdell et al. (6) initially suggested that testosterone elevated activity in 
gonadectomized female rats, but not in males.  Unfortunately, this project was 
unrepeatable and was later withdrawn (7).  Jakubcazak (60) was more successful and 
noted significantly elevated wheel running in castrated rats treated with testosterone.  
Daan et al. (20) observed a similar response in rats housed in 24 hours of darkness; 
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testosterone effectively abolished the orchidectomy-induced wheel running deficit. 
 Broida and Svare (12) evaluated the effects of testosterone in two inbred strain of 
mice (C57BL/6J and DBA/2J) and one outbred strain (Rockland-Swiss).  Interestingly, 
the response to castration in the three strains of mice was different.  The Rockland-Swiss 
were unaffected by castration (wheel running remained normal) and implantation of 
testosterone-containing silastic capsules prevented the development of a running 
deficiency in the inbred mice (12).  Unfortunately, the circulating levels of steroids were 
not quantified and it is possible that the differences were due to poor or inadequate 
laboratory techniques.  The differential response observed between species (rats versus 
mice) and amongst genetically distinct rodent strains (inbred versus outbred) suggests a 
higher level of complexity regarding steroid responsive wheel running effects. 
 Effects of Androgen Receptors and Aromatase Complexes on Activity:  
Correlation studies of testosterone levels and wheel running activity allow the genetic and 
differential complexity to be evaluated in a more systematic fashion in inbred mice.  A 
single correlation study (24) was completed in the 1970s and graphically summarized in 
Figure 2.  Eleftheriou et al. (24) evaluated the levels of testosterone and wheel running in 
eleven recombinant inbred strains, progenitors, and F1 hybrid crosses.  There was no 
correlative association between wheel running and testosterone levels across these 
genetically related mouse strains.  Eleftheriou et al. (24) concluded that the variation 
between strains was related to a genetic predisposition and not because of different levels 
of plasma testosterone; changes to testosterone levels (due to selective changes in genetic 
background) were not required for activity regulation. 
 Roy and Wade (114) further evaluated the androgens’ abilities to alter physical 
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activity patterns in rodents.  Using two sources of androgens, testosterone propionate and 
dihydrotestosterone propionate, Roy and Wade (114) were able to distinguish between 
the estrogen independent and estrogen dependent (androgens converted to estrogens prior 
to eliciting effects) effects of the androgens.  Testosterone propionate readily converts to 
17β-estradiol in the orchidectomized rat, while dihydrotestosterone propionate remains in 
an androgenic and non-aromatizable form (114).  Wheel running was increased by 
administration of testosterone propionate, but remained depressed after administration of 
the non-aromatizable androgen.  Taken together, the data from Eleftheriou et al. (24) and 
Roy and Wade (114) provide substantial evidence that any androgenic effects on activity 
pattern are dependent upon estrogens. 
 The assertion that androgenic effects on activity are dependent upon estrogens has 
been inadvertently and non-scientifically substantiated by the relative paucity of 
androgen/activity research from the 1970s to the late 1990s.  With a single article (12) 
published in the area and more than 15 articles published regarding estrogens effects, it 
was clear that activity was assumed to be dependent upon estrogens and that in regards to 
physical activity, the androgens were simply precursory sources of this activity regulating 
sex steroid.  However, several discoveries in the past 12 years have challenged the 
previously accepted estrogen-dependent hypothesis of androgenic activity regulation. 
 Initiating the reinvestigation of the androgenic role in activity regulation was a 
study in 1998 by Perret-Sinol and coauthors (96) that observed a significant correlation 
(r=0.546, p<0.05) between activity levels and testosterone levels in wild-caught male 
meadow voles.   Supporting these correlational findings, Flynn et al. (29) used 
vinclozolin, a environmental hormone disrupter with anti-androgenic properties to 
 
 
16 
evaluate wheel running activity in rats.  Both male and female rats were exposed to the 
chemical during gestation (mothers exposed to chemical in their food) and continued 
exposure after weaning via food intake.  The rats with the highest dosage of vinclozolin 
(750 ppm) exhibited lower activity compared to controls.  Flynn and coauthors concluded 
that the behavioral changes observed in these animals were due to an inhibitory 
interaction with the androgen receptor (29). 
 Inhibition or elimination of the aromatase complex in a living organism would 
allow for valuable assessment of the need for estrogens in order to regulate activity 
levels.  Hill et al. (49) generated mice that did not express the aromatase complex 
(Cyp19) gene which resulted in mice that lack estrogens.  The Cyp19-knockout males 
exhibited high levels of wheel running, exceeding wild type mice by a factor of two (49).  
Interestingly, the administration of 17β-estradiol reverted wheel running to the levels 
observed in the wild type mice (49).  It was suggested that the lack of estrogens allowed 
artificial depression of catechol-O-methyl transferase, an enzyme involved in the 
degradation of dopamine and other catecholamines (49).  Conversely, Watai and others 
(145) observed decreased wheel running in aromatase knockout mice as compared to the 
wild type mice.  Administration of estrogens altered wheel running in the male 
knockouts, but not in the female knockouts.  The differences in these studies is difficult 
to reconcile and although the use of knockout animals has been invaluable to science and 
the discovery of biological mechanism, limitations exist (16).  These differences and 
limitations require further study utilizing alternative techniques including administration 
of pharmacological agents and other potent anti-androgens to manipulate components of 
the androgenic system. 
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Are Physical Activity Patterns Defined during Neonatal Development? 
 Running wheel activity appears to be a relatively stable phenotype in inbred 
strains of mice (71).  Speculatively this stability may be the product of development 
during the prenatal stages of life.  The individual sex effects resulting from exposure to 
the sex steroids during this stage of life may carry developmental consequences and 
provide a priming stimulus that program female rodents to be more active than male 
rodents.  To investigate this suggestion, several studies have been completed in which 
activity was measured in rodents exposed to high levels of estrogens or androgens during 
natal development (38, 39, 65, 67, 126). 
 Kennedy (67) compared the wheel running activity of normal male and female 
rats to androgenized female rats.  The androgenized animals received an androgen bolus 
containing 1.25 mg of testosterone propionate either 5 days prior to birth (pre-natal), 2 
days after birth, or 6 days after birth.  Kennedy (67) did not observe significant 
degradations in activity in any of the groups despite serious alterations to mating and 
sexual behaviors.  Gerall (38) provided estrogen and androgen boluses to 5 days old 
intact or spayed female rats and compared wheel running to intact and spayed controls.  
The spayed animals lacked running vigor regardless of injected substrate.  The 
estrogenized rodents with functional ovaries ran similar distances to the intact control 
rats.  Based on the data from Gerall (38), it appeared that the presence of estrogens during 
infancy and an estrogen source beyond infancy were required to stimulate wheel running 
activity, an effect not necessarily caused by androgens. 
 Kawashima and Shinoda (65) further evaluated the necessity for the persistent 
presence of estrogens after neonatal development.  These coauthors (65) estrogenized 
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female rats which lead to a group of rats that were persistently in estrous (elevated 
estrogens throughout development) and a group that were persistently in diestrus 
(deflated estrogens levels).  The persistent estrous group ran as much as controls; the 
persistent diestrus group ran significantly less than controls.  After ovariectomy, both 
groups had greatly reduced wheel running, an effect that was reversible with estrogen 
administration in the persistent estrous group, but only partially recoverable in the 
diestrus group (65). 
 Gerall (39) further investigated the effects of androgenization on wheel running in 
female rats using multiple concentrations of androgens and observed low wheel running 
levels only in animals with the largest dosage of androgens.  Administration of estrogens 
had no effect on wheel running in these rats and suggested an ability for neonatal 
androgen administration to prevent estrogen function during the adult portion of life (39). 
The development of running drive during the neonatal stages of life has also been 
shown to persist into adulthood even if estrogens are not present (126).  Stern and 
Jankowiak ovariectomized rats at birth and administered estrogens on days 2 and 4.  
These animals aged to adulthood and then were measured for wheel running.  Wheel 
running was habitually low, but could be reinvigorated upon estrogen administration 
(126).  Currently, there are no available estrogenization or androgenization studies 
utilizing male rodents.  The current literature suggests that the development of wheel 
running vigor is established very early in the rodent life cycle, persists throughout life 
regardless of hormone status, and requires an estrogenic source for development and 
promulgation during adulthood.  The effects of androgens in the development and 
perpetuation of wheel running in neonatal and adult rodents remain unclear. 
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Are Physical Activity Patterns Regulated by the Progestins in Rodents? 
 The progestins have rarely been the focus of activity regulation studies.  The 
studies that have included progestins, mostly progesterone, in their study design have 
usually focused on the steroid as a secondary variable.  Young and Fish (151) evaluated 
the effects of estradiol benzoate and estrone on activity and noted no effect during a side 
experiment in which progesterone was administered to animals receiving estrogen 
treatments.  In 1964, Hervey (47) injected 5 mg of progesterone per day for 12 days to 
normal, intact female rats.  Wheel running was assessed in these animals during estrous 
and non-estrous portions of the cycle before and immediately after injections (47).  
Wheel running was highest prior to injections and during estrous (Figure 3) and 
decreased during the non-estrous phases of the cycle, but the cyclical behavior observed 
in the normal rat was abolished in the presence of progesterone (47). 
 Rodier (111) expanded the experiments of Hervey (47) and controlled estrogen 
levels via ovariectomy.  Again, the normal, intact rats had reduced wheel running during 
progesterone administration, but after ovariectomy, progesterone’s effects were obscured.  
Progesterone required the presence of estrogen for its inhibitory effects to be observed, 
but under the conditions of ovariectomy, activity reached a nadir (≈15,000 revolutions → 
≈1,000 revolutions).  This apparent nadir may mask the effects progesterone has on 
activity by preventing the large and significant fluctuations observed in the 
reproductively intact animal (111).  Rodier and Segal (112) evaluated activity during 
normal and low estrogen conditions in rats chronically deprived of food.  Under these 
conditions the effects of progesterone administration on activity remained depressive, but 
the element of food deprivation added additional variability.  The coauthors (112) found 
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that food deprivation eliminated the inhibitory effects of progesterone in the normal 
cycling rodent. 
 Unfortunately, the effects of progesterone on activity regulation remains highly 
understudied.  Based on the currently available literature, progesterone’s effects appear to 
be inhibitory.  Furthermore, in order for progesterone to modulate activity, a rat’s 
estrogen levels (leading to elevated activity) must be pronounced, as is typical during 
estrous.  Further, the physiological and behavioral changes associated with food 
deprivation block progesterone’s effects. 
 Similar to the progestins, the androgens and estrogens appear to elicit substantial 
activity regulation effects in rodents (see Figure 4).  The value of basic animal literature 
is defined by its ability to translate into useful human biology related knowledge.  
Compared to the available basic scientific literature, literary sources detailing sex steroid 
regulation of human activity levels remain primarily unavailable.  The remainder of this 
review is devoted to the literature investigating activity patterns in humans across various 
sex steroid conditions. 
Are Physical Activity Patterns Regulated by the Sex Steroids in Humans? 
 The available animal literature (see ref. 81 for a current review) strongly suggests 
the presence of a physical activity regulating mechanism centered around sex steroid 
physiology.  In rodents, wheel running is reduced after surgical or pharmacological 
gonadectomy and is increased after hormones are reintroduced via capsules or injections.  
The necessary ethical limitations of human subjects research have limited the use of such 
experimental manipulations in humans leading to a reduced understanding of the 
biological mechanisms present in humans contributing to physical activity regulation.  
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Through use of natural (due to sex, aging and the menstrual cycle) and artificial changes 
in clinical populations (pharmacological and hormone replacement therapies), limited 
research has been compiled to evaluate the extent to which sex steroids regulate activity 
in the human population. 
 Are females and males differentially active:  If sex steroids play a role in the 
regulation of daily activity patterns, it is appropriate to hypothesize that male and female 
activity patterns would differ, especially given the cyclical nature of sex steroids in 
females.  The extensive animal literature (81) shows that female rodents, in general, are 
more active on a daily basis than male rodents, regardless of the measurement used.  
Interestingly, the majority of literature investigating this question in humans shows that 
human females, whether child, adolescent, or adult, are less active on a daily basis than 
males.  Pate and colleagues, in an extensive review of physical activity in adolescents 
showed that female children and adolescents were generally less active than males (95).  
This trend continues into adulthood; Figure 5 represents findings from the 2001 (85, 86) 
and 2007 (1) United States Behavioral Risk Factor Surveillance Survey (BRFSS).  In 
2001, over 200,000 individuals were surveyed.  A greater percentage of males expressed 
meeting the physical activity recommendations for moderate and/or vigorous exercise 
than did adult females.  The 2007 dataset was expanded to include over 400,000 subjects, 
and resulted in an even larger activity gap between the sexes.  These results also extended 
to overweight and obese adults.  Recent accelerometer data (Figure 5) from Troiano et al. 
(134) from the 2003-04 National Health and Nutrition Examination Survey (NHANES) 
showed the same qualitative pattern—males were slightly more active than females—but 
compared to the BRFSS data, showed a significantly lower number of individuals 
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actually complete moderate activity.  The same male-female differential activity pattern 
has also been observed in the non-technical Old Order Amish culture (8) as well as in 
several hunter/gatherer cultures (Figure 6 - the Nuñoa and Tamang being notable 
exceptions) indicating that in general, regardless of culture, males are more active than 
females (80, 93).  Therefore, in contrast to the well-established rodent literature, the 
majority of the available literature suggests that human males are more active than human 
females (81).  The causes of differential activity levels in humans are not entirely known; 
however, measurement of activity levels surrounding naturally or artificially induced 
changes in sex steroid concentrations may enhance our understanding of the sexually 
differentiated activity pattern. 
 Is there a difference between activity levels before and after menopause:  The 
transition in female humans at menopause allows activity to be compared under two very 
different hormonal circumstances.  Prior to menopause, the sex steroids circulate in 
higher concentrations compared to the concentrations experienced after menopause.  
Unfortunately, the scientific literature has yet to address this question directly or in 
sufficient detail.  In one indirect study, Dorn et al. (21) investigated breast cancer risk in 
pre- and post-menopausal women with and without breast cancer.  As a component of 
this analysis, the researchers asked the subjects to recall their strenuous physical activity 
patterns during the previous two years.  Due to their illness, the patients with breast 
cancer likely had activity patterns that were deviant from normal and therefore were not 
considered for this review.  Unfortunately, statistical comparisons were not made 
between the two control groups to directly evaluate pre- and post-menopause activity 
levels; however, these subjects estimated their yearly strenuous physical activity to be 
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77.3±127.8 h·yr-1 in women prior to menopause and 68.4±176.7 h·yr-1 in women after 
menopause (21).  While it is tempting to infer a decrease in activity after reductions in 
steroid concentration following menopause, the considerable variation in the activity 
measurement and the varying age of the subjects significantly complicates this 
comparison.  Thus, while the literature is limited, the use of both cross-sectional and 
longitudinal studies measuring activity levels pre- and post-menopause is certainly 
warranted. 
 Does physical activity change across the menstrual cycle:  Examination of 
activity patterns in eumenorrheic women provides a hormonal concentration milieu that 
is unique.  Tworoger and colleagues (137) reported the results of a carefully crafted 
correlational study that used data from 565 pre-menopausal women, ages 33-52 yrs, that 
were originally surveyed in the Nurses’ Health Study II.  The investigators measured a 
wide-variety of sex steroids in blood samples taken during the luteal and follicular phases 
of the menstrual cycle in woman that varied in amount of physical activity preformed 
during a typical week as gathered through self-report questionnaires.  These authors 
noted that while in general there were no strong associations between physical activity 
and testosterone, progesterone, or follicular estradiol levels, there was an inverse 
association (p=0.05) between activity and luteal estrogen levels.  Unfortunately, 
interpretation of any relationship between activity levels and estrogen levels in this study 
is difficult because body fat levels were lower in those women that were more active.  
Given that adipose tissue can increase estrogen levels (149), the lower body fat levels of 
the active women could have confounded the negative relationship between activity 
levels and estrogen levels in this study. 
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 Do hormone replacement therapies or pharmacological interventions alter 
activity levels:  Females— As noted earlier, there is extensive rodent literature suggesting 
that estrogen in particular, but also testosterone (81), increases activity levels via 
activation of the estrogen alpha-receptor pathway leading to downstream regulation of 
other physiological structures, potentially in the brain.  While limited data exists to 
answer whether this is also true in humans, the studies that have been done have 
addressed the effect of hormone replacement therapy (HRT) on physical activity in 
women.  Using a correlational design, Andersen et al. (3) observed that in the NHANES 
III data, women who had never used HRT reported higher levels of inactivity (40%) as 
compared to those women who had used HRT (28.5%) suggesting that women who had 
not used HRT (decreased estrogen) were more likely to be sedentary (decreased activity) 
when compared to those women that had used HRT.  While supporting the hypothesis of 
sex steroid effects on activity levels, a major limitation of the NHANES III data was that 
it surveyed leisure time activity alone without regard for activities of daily living.  Thus, 
any women that did not report any leisure time activity were classified as 
sedentary/inactive in spite of potential vigorous activity completed as part of their daily 
lives.  Another research design issue with this data was the lack of control for the type of 
HRT or delivery method used (e.g. oral or transdermal; see below for further 
consideration). 
 Redberg et al. (102) stratified 248 post-menopausal women based on their HRT 
use and interviewed them regarding their physical activity, with physical activity levels 
estimated as Mets·h/wk (Figure 7A).  The physical activity data were analyzed across 
four different groups (each subject was included in one or more of the experimental 
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groups): those women currently on HRT (n=108) versus those not currently on HRT 
(n=140) and those women who were currently or had been on HRT (n=158) versus those 
who had never used HRT (n=90).  Ninety-four percent of the HRT subjects (n=101) used 
oral estrogen therapy while transdermal estrogen was used in six percent of the subjects 
(n=7).  Of the group currently using HRT, 48% were on combined estrogen/progestin 
supplementation with the composition of the HRT for the remainder of the subjects not 
noted.  Redberg and colleagues (102) reported large variability in physical activity in 
each group (Figure 7A) with no significant differences between any of the groups, thus 
concluding that activity was not affected by HRT status. 
 Anderson et al. (4) conducted a repeated measures trial on younger (45-55 yrs, 
n=18) post-menopausal and older (70-80 yrs, n=15) post-menopausal women 
investigating the effect of transdermally applied estrogen and estrogen plus vaginally-
applied progesterone supplementation on a variety of energy balance measures with a two 
month clearance between treatments.  This study was unique in that the estrogen and 
progesterone treatments were carefully titrated to result in near physiological circulating 
levels of both estrogen (76.89±4.43 - 80.50 ±5.43 pg·ml-1) and progesterone (7.09±0.91 
ng·ml-1).  Furthermore, the subjects were encouraged not to lose weight while in the 
experimental program.  Figure 7B shows that Anderson and colleagues (4) observed no 
differences in physical activity level as measured by survey techniques across the 
treatments, thus supporting the lack of an effect of HRT on activity levels. 
 Kenny and colleagues (69) completed a three-year double blind, placebo-
controlled trial investigating the effect of estrogen therapy on various muscle and 
physical functions in 167 older (average age at baseline ≈ 74 yrs) post-menopausal 
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women.  The women were randomly assigned to either an estrogen treatment group (0.25 
mg oral 17β-estradiol) or a placebo group (Figure 7C).  Physical activity was estimated at 
the beginning of the study and then once per year for the three year trial using the 
Physical Activity Scale in the Elderly (PASE).  Kenny et al. (69) reported that while the 
baseline activity scores were different between the groups, the rate of decrease in activity 
during the three years was the same in all of the groups. 
 Poehlman et al. (101) published a purported six-year controlled longitudinal study 
of HRT and energy balance that supposedly showed an increase in leisure time activity 
with HRT.  Unfortunately, this article was subsequently retracted from the literature 
when the author admitted to fabricating the data in the study (100, 124, 125). 
 Males— In males, there are two possible avenues that could be used to artificially 
manipulate sex steroid levels in order to evaluate effects on activity.  In one approach, the 
effects of antiandrogens (e.g. flutamide)—often prescribed for individuals at risk of or 
suffering from prostate cancer, as well as those suffering from a severe sexual disorder—
on activity could be considered.  However, there have been no published investigations 
on the effects of antiandrogens on physical activity in humans.  A second avenue would 
be to consider the effects of supra-pharmacological doses of androgens on activity.  
While there are anecdotal statements of hyperactivity in individuals taking supra-
pharmacological doses of androgens (115) there have been no studies that directly or 
indirectly measured physical activity levels in these subjects.  There is a large body of 
literature concerning aggression with androgen supplementation in both men and women.  
Unfortunately, using the data on androgen supplementation and aggression to infer 
possible linkages between androgen supplementation and physical activity levels is 
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difficult due to the possible confounding effects of the various psychological states 
occurring with supra-pharmacological doses of androgens and the uncertainty regarding 
gonadal sufficiency of the subjects. 
 The human data available regarding the sex steroid effects on activity are sparse 
and the existing literature is limited to female subjects.  While the female correlational 
data are split, with one study showing a positive relationship between lack of HRT and 
inactivity (3) and one showing no relationship (137), all of the available prospective 
studies (4, 69, 102) do not support the contention that estrogen administration alters 
physical activity in humans.  These studies are strong from the standpoint that in each 
case, total daily physical activity levels were estimated as opposed to estimation of just 
leisure time activities as was the case with the NHANES III data (3).  However, 
definitive conclusions are difficult to reach due to several possible confounding research 
design factors. 
Are Research Design Issues the Reason for Species Difference in Sex Steroid Effects 
in Rodents and Humans? 
 Animals, especially rodents, have been used to model phenotypes or physiological 
phenomenon in humans with reasonable success.  However, as has been discussed, the 
animal data show conclusively that sex steroids—specifically estrogen—exert powerful 
effects on daily activity, while the limited human data suggests that sex steroids play no 
role in the biological regulation of activity.  Thus, the species difference in sex steroid 
effects on activity requires the consideration of several factors including 1) 
appropriateness of the animal model, 2) how dependency is assigned to variables, 3) 
whether rodent modes of activity directly translate to the measurement of activity in 
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humans, and 4) how the steroids are replaced or introduced to the organism.  These 
factors help to outline the limitations of animal to human translation in physical activity 
level research and provide a foundation for future investigations in both humans and 
animal models. 
 Appropriateness of rodents as models of human physiology:  Any consideration of 
species differences, especially differences between rodents and human models, must 
begin with questioning the appropriateness of using rodents to investigate human health 
questions.  A variety of scientific organizations recognize the usefulness of rodents in 
modeling human physiology, especially with less than 1% of the mouse genome differing 
significantly from the human genome (146).  Specifically, rodents are used frequently as 
models of human sex steroid physiology; in 2006 and 2007, the National Library of 
Medicine listed 881 articles that were published concerning mice and reproductive 
hormones.  For example, rodent models have been used extensively to document the role 
of estrogen α and β-receptors (ERα and ERβ) in human cardiovascular physiology (5).  
Therefore, it is reasonable to suggest that data collected in rodents on the effect of sex 
steroids on physical activity can be applied to human physiology. 
 Independent versus dependent variables:  Another factor that confounds the 
determination of whether sex steroids play a causative role in the regulation of daily 
activity in humans is experimental design issues, especially the assignment of 
independent/dependent variable relationships.  While the animal literature has primarily 
studied the effect of sex steroids (i.e. independent variable) on physical activity (i.e. 
dependent variable), the majority of research in the human literature has approached 
physical activity as the independent variable, with sex steroid levels treated as dependent 
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variables.  This approach is somewhat understandable given the belief that activity levels 
were controlled by voluntary directives and not the product of biological factors and thus, 
could not be affected by biological manipulation.  With mounting evidence that 
‘voluntary’ physical activity levels may actually be driven to a significant extent by 
biological/genetic factors (82, 83, 117, 130), it becomes important to understand the 
factors—such as sex steroids—that regulate daily activity.  The understanding that there 
are discrete biological/genetic factors that drive ‘voluntary’ physical activity calls for 
further carefully controlled studies—in addition to the three studies currently available (4, 
69, 102)—where activity level is the dependent variable with sex steroid 
level/supplementation as the independent variable.  This approach would allow further 
understanding in the human model of the role of sex steroids—much as has been done in 
the animal literature. 
 Use of surveys to determine physical activity:  The use of surveys or 
questionnaires to estimate physical activity levels in all of the current human studies 
limits conclusions.  Numerous reviews (e.g. ref. 116) have observed that survey 
estimations of physical activity generally overestimate actual activity levels.  This was 
reinforced recently by Troiano and colleagues (134) when they measured daily activity in 
a large population using accelerometers and found only a small percentage (3.5±0.3%) of 
adults completed moderate activity on a daily basis as compared to other survey estimates 
of adult activity levels (e.g. 45.4±0.2%, ref. 85).  As noted in an extensive review of the 
reliability, validity, and sensitivity of physical activity questionnaires (116), correlation 
coefficients between measurement of physical activity (e.g. doubly-labeled water or 
accelerometers) and questionnaire results vary widely with few rising above 0.60 and 
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with the questionnaires generally overestimating activity levels.  Specifically, two factors 
that often lead to the least valid estimates of activity are the length of time separating the 
recall from the activity and individuals whom have lower levels of activity (116).  It is 
difficult to determine the possible effect of these two confounding factors on the 
conclusions of the currently available prospective HRT studies (4, 69) given that none 
listed the recall period that was used in their studies even though the instruments used by 
Kenny et al. (69) and Anderson et al. (4) were designed to estimate daily activity based 
on a seven day recall period.  Therefore, to eliminate the possible confounds of using 
survey/questionnaire approaches which grossly overestimate daily activity, the use of 
direct measures of activity, such as was done in the NHANES 03-04 study (134) would 
considerably strengthen the investigation of sex steroid effects on daily activity levels. 
 Mode of hormone therapy used:  The method of hormone delivery can 
significantly influence the circulating concentrations of sex steroid (135).  For example, 
plasma concentrations of orally delivered steroids reach peak physiological levels 
approximately three hours after administration and then declines rapidly (135) exposing 
the individual to a non-physiological pattern of sex steroid concentration over the course 
of a 24 hour period.  The use of transdermal administration provides a more stable plasma 
concentration of hormone, but to this point, only one of the prospective studies (4) used 
transdermal administration and verified constant, physiological concentrations of the sex 
steroids in their subjects. 
 Additionally, other than the Anderson et al. (4) study, no study has delineated the 
type of estrogen/progesterone used in prospectively assessing the effect of sex steroids on 
activity.  Both the ERα and ERβ preferentially bind to certain estrogenic substrates.  As 
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noted earlier, the estrogen-α receptor pathway has been shown to be the primary pathway 
involved in physical activity regulation.  With different estrogens and progestins used in 
common HRT formulations (135) and the hypothesized activity inducing actions of the 
estrogen-α receptor pathway (81), it is possible that different HRT formulations produce 
different physical activity responses solely due to the lack of a compound with the 
necessary ability to bind to the estrogen-α receptor. 
 Thus, while the limited human data suggests that female activity patterns are not 
influenced by sex steroids, given the methodological limitations present, this conclusion 
is tentative at best and misleading at worst.  Future studies controlling type and 
concentration of hormone replacement, the use of research designs that recognize that 
activity levels are influenced by biological factors, and the direct measurement of daily 
activity will provide further information to support or refute this hypothesis.  However, 
while speculative, if we assume that the current human data are representative of the 
human activity response to sex steroids, the question of why there is a species difference 
in the activity patterns of female rodents versus humans remains enigmatic. 
Summary and Conclusions 
 There is no doubt that increasing physical activity levels in adult populations, 
both nationally and internationally, should be a health-related priority and the fact that 
general levels of physical activity in both adults and children are less than optimal (e.g. 
refs. 95, 134) is troubling.  Decades of activity promotion and research have not produced 
a noticeable reduction in the number of inactive individuals.  Thus, these data present a 
clarion call for a greater understanding of the underlying mechanisms regulating 
voluntary daily activity and the roles that biological/genetic factors play in activity 
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regulation.  The plethora of epidemiological evidence that suggests that human females, 
in most cases, are less active than males, along with increasing rates of cardiovascular 
disease in women (31), provides additional impetus for understanding all factors involved 
in activity regulation.  In spite of the strong animal literature that suggests a probable 
physiological mechanism of activity regulation by sex steroids (81), human females are 
still generally less active than males.  Thus, the question becomes and remains as to 
whether the environmental/cultural influences on physical activity override the increased 
physical activity drive inherent in women. 
 While there is some literature suggesting differential environmental, cultural, and 
psychological effects on activity levels between the sexes, there is no literature available 
investigating the interaction of these factors and biological effects on activity.  Further 
study is warranted that specifically sets hormone concentration as an independent 
variable.  Ideally, experimental modulation of hormone levels in a wider variety of 
individuals is necessary to completely understand the influence hormone levels have on 
activity.  Such studies should capitalize on current therapeutic intervention used by 
medical professionals to manage endocrine related diseases and disorders including birth 
control administration, testosterone treatments, and hormone replacement therapy.  The 
naturally occurring variation of hormone levels in both males and females throughout the 
life cycle, during distinct physiological conditions such as the luteal and follicular phases 
of the menstrual cycle, and between individuals may also add appropriate and measurable 
variability that allows independence to be assigned to hormone concentration.  
Additionally, the more reliable estimation of activity achieved through use of 
accelerometers and other quantifiable forms of locomotion measurement should be 
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utilized in place of traditional survey methods. 
 The clinical implications of expanding this research are potentially far reaching.  
Currently, a large body of literature exists regarding how extrinsic and environmental 
factors influence physical activity levels in humans; unfortunately, beneficial alterations 
to health indicators are minimal and physical inactivity and related conditions remain 
disproportionately high.  Thus, physical activity management strategies and research 
agendas that focus solely on environmental or extrinsic factors are shortsighted.  The 
overall goal of physical activity-sex steroid interaction research should be to further 
delineate biological pathways and identify enzymes/proteins/biomolecules involved in 
up-regulating activity levels in humans.  In doing so, the medical community may in fact 
find ways in which to capitalize on these biomolecules and pathways leading to 
promotion of physical activity and increased beneficial health outcomes in the general 
population. 
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Figure 1:  Basic pathways for sex steroid biochemistry in mammalian species.  Double-
headed arrows represent reversible reactions; single-headed arrows represent one-way 
reactions.  The general sex steroid classes are grouped in dashed boxes. 
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Figure 2:  This figure shows the lack of a relationship between testosterone levels and 
wheel running activity in progenitor strains (BALB/cBy and C57BL/6By), F1 hybrids 
(B6CF1 and CB6F1), and recombinant inbred strains (CXBD, CXBE, CXBG, CXBH, 
CXBI, CXBJ, CXBK).  Figure redrawn from tabular data presented by Eleftheriou et al. 
(24). 
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Figure 3:  The effects of progesterone administration during estrous and non-estrous 
portions of the estrous cycle in female rats.  Figure adopted from tabular data presented 
by Hervey (47).  No statistical comparisons were made in the original dataset. 
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Figure 4:  Schematic diagram of hypothesized estrogen, androgen, and progestin-derived 
pathways involved in the regulation of physical activity levels in male and female 
rodents. 
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Figure 5:  Percentage of U.S. adults meeting moderate/vigorous activity 
recommendations.  Males are the hatched bars and females are the open bars.  The total 
data included all subjects, overweight data included subjects with a BMI between 25.0 
and 29.9 kg·m-2, and obese data included subjects with a BMI ≥ 30.0 kg·m-2.  Data 
redrawn from United States 2001 (85, 86) and 2007 (1) Behavioral Risk Factor 
Surveillance Survey (BRFSS) and the 2003-2004 (134) National Health and Nutrition 
Examination Survey (NHANES).  BRFSS data are presented as the whole dataset (1, 85) 
and subdivided by weight status (86). 
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Figure 6:  Hours per day of moderate-vigorous activity in Hunter/Gatherer cultures.  
Males are the hatched bars and females are the open bars.  Data for the Nuñoa, Kaul, 
Lufa, and Ju/’hoansi populations are redrawn from Leslie et al. (80) and data for the 
Tamang population are redrawn from Panter-Brick (93).  Note: The Ju/’hoansi people are 
referred to as !Kung in the manuscript (80) in which these data were taken.  This 
terminology refers to the language spoken by the Ju/’hoansi peoples and is now 
considered offensive and derogatory (78). 
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Figure 7:  The effect of hormone replacement therapy (HRT) on physical activity.  Panel 
A represents the lack of difference in physical activity estimates amongst any of the HRT 
and non-HRT groups and represents tabular data from Redberg et al. (102).  Panel B 
shows the lack of an effect of HRT, both estrogen (E2) and estrogen plus progesterone (E2 
+ P) treatments, on estimated activity levels in younger menopausal and older 
menopausal subjects.  Data taken from Anderson et al. (4).  Panel C represents the lack of 
a difference in estimated physical activity between low-dose estrogen and placebo over a 
36-month period.  *Indicates a significant difference from placebo treatment at same time 
point.  Data taken from Kenny et al. (69). 
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Table 1.  The effects of ovariectomy, ovarian traumatization, and chemical gonadectomy on 
physical activity patterns in rodents 
Study Species--Strain Procedure % difference from 
baseline or 
control animals 
Wang (141) Rat Ovariectomy 18.8 
Durrant (22) Rat--White Ovariectomy 34.0 
Bugbee & Simon (15) Rat Ovariectomy 69.5 
Wang & Guttmacher (143) Rat Traumatization 9.1 
Richter & Hartman (108) Rat Ovariectomy 16.7 
Young & Fish (151) Rat Ovariectomy 15.0 
Richter & Uhlenhuth (109) Rat Ovariectomy 5.4 
Asdell et al. (6)* Rat Ovariectomy 200.0 
Gorzek et al. (43) Mouse--C57BL/6J Ovariectomy 13.0 
Hydock et al. (57) Rat--Sprague Dawley Chemical  42.9 
*Asdell at al. (7) provided a correction to their 1962 paper, citing an inability to repeat all 
aspects of the previously published paper 
 
 
Table 2.  The effects of orchidectomy and castration on physical activity patterns in rodents 
Study Species--Strain Procedure % difference from 
baseline or 
control animals 
Gans (34) Rat Fractional Castration 22.2 
Gans (35) Rat Early Castration 110.0 
Hoskins (54) Rat Castration 25.3 
Hydock et al. (57) Rat--Sprague Dawley Chemical 47.1 
 
CHAPTER 2: 
EFFECTS OF SUPRA-PHYSIOLOGICAL DOSES OF SEX STEROIDS ON WHEEL 
RUNNING ACTIVITY IN MICE 
 
 
Abstract 
 The regulatory mechanisms of physical activity are postulated to include 
environmental and biological/genetic factors.  In particular, the sex steroids appear to 
have profound effects on wheel running in rodents.  The purpose of this project was to 
investigate the effects of 17β-estradiol and testosterone on wheel running distance, 
duration, and speed in male and female C57BL/6J mice.  The mice (N=46) were provided 
free access to running wheels interfaced with computers to track daily running distance, 
duration, and speed.  Activity was assessed at baseline in intact mice, after surgical 
gonadectomy, and after replacement with either 17β-estradiol or testosterone.  Upon 
removal of the gonads, physical activity levels were significantly reduced in both males 
and females.  Distance (10-30% of baseline) and duration (20-47% of baseline) measures 
were most affected by the loss of endogenous steroids, while running speed (60-77% of 
baseline)—though significantly reduced—decreased by a much lower magnitude.  
Testosterone replacement fully recovered running distance, duration, and speed to pre-
surgical levels in both sexes (100% of baseline).  Distance (30-42% of baseline) and 
duration (43-47% of baseline) were partially recovered by 17β-estradiol, but not to 
baseline levels.  Speed (100% of baseline) was fully recovered by 17β-estradiol 
replacement in males and females.  This study suggests that physical activity in mice is
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affected by endogenous steroids and can be altered by exogenous steroid replacement.  
The differences in the recovery abilities of 17β-estradiol and testosterone suggest that 
both estrogenic and androgenic pathways may be involved to variable degrees in activity 
regulation. 
Introduction 
 Physical inactivity enhances the risk of many diseases including obesity, diabetes, 
many types of cancer, and heart disease (87).  The US health care system is excessively 
burdened by hypokinetic related diseases, resulting in reduction in service and care.  
Furthermore, quality of life parameters are significantly degraded as inactivity-induced 
diseases progress.  To understand the mechanisms inducing physical inactivity within the 
human population, efforts to elucidate the biological and genetic factors that alter either 
the motivation or ability to partake in increased activity are necessary. 
 The sex steroids have previously been shown to influence physical activity in 
rodents and may be important biological factors regulating activity levels.  Gorzek et al. 
(43) altered 17β-estradiol levels in young female mice by surgically removing their 
ovaries followed by replacement in a capsulated form.  The study showed a significant 
decrease in voluntary wheel running distance following ovariectomy and a recovery back 
to pre-surgery levels when capsulated 17β-estradiol was administered.  A similar 
response has been shown in male rats after castration (144).  Several other studies report 
comparable effects (15, 54, 55, 141, 151); however, with the exception of the study by 
Gorzek et al. (43), these studies were conducted in the 1920s prior to the discovery and 
purification of many of the chemicals involved in activity regulation.  The results from 
these studies, though unique and novel for the early parts of the 20th century, are 
 
 
45 
outdated and require revision using newly available delivery techniques, measurement 
apparatuses, and purified steroid samples. 
 In a seminal study, Roy and Wade (114) administered dihydrotestosterone 
propionate, a non-aromatizable form of testosterone, to castrated male rats and found no 
significant change in activity levels suggesting that an estrogen-aromatase dependent 
mechanism was responsible for activity regulation by the sex steroids.  Additionally, 
using estrogen receptor α (ERα) and β (ERβ) knock-out mice, Ogawa et al. (92) 
demonstrated  alterations in wheel running via ERα, but not ERβ pathways.  Finally, it 
has been hypothesized that changes to activity in murine systems due to changes in sex 
steroid levels may be due in part to undiscovered non-genomic effects and/or intricate 
interactions between estrogens, ERα, and dopaminergic neurons (81). 
 The purpose of this study was to systematically remove and replace both 17β-
estradiol and testosterone in male and female mice allowing comparisons to be made 
between the steroids and sexes in the regulation of running wheel activity.  Alteration in 
running distance or number of wheel revolutions has been the flagship measure defining 
physical activity levels in mouse models (15, 22, 43, 54, 55, 120, 142, 144, 151);  newer 
techniques now allow running duration and speed to be quantified as well.  Thus, a 
secondary purpose of this study was to evaluate the changes in running distance, 
duration, and speed in a murine model of physical activity under minimal and supra-
physiological levels of circulating sex steroids. 
Methods 
 Animals:  This project conformed to standards of humane animal care and 
received approval from the UNC Charlotte Institutional Animal Care and Use Committee 
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prior to initiation.  C57BL/6J inbred mice (Jackson Laboratory, Bar Harbor, ME) were 
used in this study due to their prevalent use in the scientific literature and because of their 
genetic homogeneity.  Twenty-three male and 23 female mice were initially used in this 
study; however, five mice (male=1; female=4) showed signs of distress following the 
surgical gonadectomy procedures and were euthanized for humane purposes resulting in 
a total cohort of 41 animals for the remainder of the study.  Prior to the start of this 
project, mice were group housed three to four per cage until they reached approximately 
9 weeks of age.  The mice were then individually housed and provided unlimited access 
to running wheels for the duration of the study.  Whereas mice reach their activity zenith 
between 9 and 12 weeks of age (133), this study  encompassed the most active parts of 
the lifespan.  Through the entirety of the study, the mice were housed under a 12:12hr 
light:dark cycle initiating daily at 6am.  Free access to water and standard mouse chow 
(Harlan Teklad, Madison, WI) was provided throughout the study.  The chow provided to 
the mice during this study was not phytoestrogen-free.  Several authors (36, 45, 46, 73, 
74) have shown that phytoestrogens do not increase activity in gonadectomized mice. 
 Experimental Procedure Overview:  The timeline for this project is displayed in 
Figure 8.  Each mouse was randomly assigned to either an experimental group or a 
control group.  This random assignment was stratified by sex and by the initial housing 
scheme in order to ensure that previous group housing effects would be minimized.  After 
separation into individual cages, each mouse was supplied a running wheel.  Wheel 
running distance, duration, and speed represented physical activity levels and were 
monitored under three experimental treatments including at baseline, after gonadectomy, 
and with supra-physiological steroid replacement (detailed below). 
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 After an initial seven-day period to assess baseline wheel running, gonadectomy 
surgeries (detailed below) were performed to reduce circulating steroid levels.  The 
control groups received sham surgeries.  A 10-day recovery period, without wheels, 
allowed the surgical wounds to heal and remaining circulating steroids to clear from the 
system.  After this recovery period, the wheels were replaced in the cages.  Wheel 
running activity was then tracked for an additional seven days. 
 Next, the implant surgeries were completed and followed by two days for 
recovery and seven days to record activity.  Silastic capsules (detailed below) containing 
17β-estradiol were implanted in eight females and nine males.  Silastic capsules 
containing testosterone were implanted in eight females and ten males.  The animals in 
the control groups were given empty implants.  The two-day recovery period allowed the 
animals to recover from surgical wounds and the silastic implants to deliver steroid into 
the bloodstream (17).  After recovery, the mice were re-exposed to running wheels and 
their physical activity levels were monitored for seven days.  At the end of each seven-
day data collection period, body masses and percentage body fat measures were 
completed.  A PIXImus 2.10 (Lunar, Madison, WI) was used to collect the percentage 
body fat measurements via dual energy x-ray absorptiometry. 
 Measurement of Wheel-Running Activity:  Physical activity was measured by 
determining daily distance, duration, and speed of wheel running using standard 
protocols (82, 136).  In brief, running wheels were mounted to the cage tops of standard 
rat cages and were equipped with a cycling computer (BC500, Sigma Sport, Batavia, IL) 
to record running distance and duration.  Running wheels had a 450mm circumference 
and a 40mm wide, solid running surface.  Running distance and duration data were 
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collected on a daily basis in the morning and average daily running speed was calculated 
from the corresponding distance and duration measures.  The sensor and magnet 
alignment and freeness of the wheel were checked daily and adjusted as needed. 
 Surgical Procedures:  Twenty males and twenty females received orchidectomies 
or ovariectomies.  The remaining six mice (3 males; 3 females) acted as control animals 
and underwent sham surgical procedures.  A preemptive dose (0.05 mg·kg-1) of 
buprenorphine was administered via intraperitoneal injection approximately 30 minutes 
prior to the gonadectomy procedures.  All procedures were performed under light 
isoflurane anesthesia with a 300 ml·min-1 oxygen flow rate.  Incisions were made under 
sterile conditions (10% betadine followed by 70% alcohol) with sterile surgical tools. 
 The gonadectomy surgery performed depended upon the sex of the mouse.  
Orchidectomy surgeries were preformed on the male mice and were initiated by making a 
small access incision in the skin directly proximal to the scrotal sac.  Additional incisions 
were made in the fascia on either side of the scrotal sac.  Slight pressure was applied just 
above the incision sites to expose the testes.  Both the testes and epididymis were excised 
and discarded.  The incision wound in the skin was closed with a surgical staple.  
Bilateral ovariectomies were preformed on the female mice.  A small incision was made 
in the skin directly above the lumbar region.  A small pocket was developed between the 
skin and muscle to allow unrestricted access to the animal’s dorsolateral region.  Small 
incisions were made in the fascia approximately 5 mm on either side of the spine just 
proximal to visible white fatty tissue.  Each ovary was exposed and excised.  The skin 
wound was closed with a surgical staple.  The sham procedures preformed on the control 
animals were identical to the procedures described above minus the excision of the sex 
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organs. 
 Replacement Procedures:  Two sets of implants were developed to release sex 
steroids into the bloodstream of the mice based on diffusion.  The silastic implants were 
produced similar to the technique of Cohen and Milligan (17), except that dry powder 
without arachis oil was packed into silastic tubing.  A 10 mm section of the silastic tubing 
(Dow Corning, Midland, MI) with an outer diameter of 2.16 mm and inner diameter of 
1.02 mm was packed with either powder testosterone or powder 17β-estradiol (Sigma-
Aldrich, St. Louis, MO).  The ends of the tubing were covered with a small bead of 
weatherproof silicone glue.  Each implant was washed in 70% alcohol for one minute and 
rinsed in deionized water.  After washing, the implant was patted dry and stored in 
Eppendorf tubes at room temperature under dark, dry conditions.  The implants for the 
control animals were prepared in the same way, but were left empty.  Surgeries to 
implant silastic capsules to replace the sex steroids were preformed during the later stages 
of this project.  A small incision was made on the lateral aspect of the neck.  A cavity 
about 15 mm in depth and width was developed between the skin and muscle tissue.  
Forceps were used to insert a 10 mm long silastic implant into the cavity.  The incision 
wound was closed with a surgical staple. 
 Sex Steroid Assays:  The current project was performed in conjunction with two 
other related projects.  Blood samples were taken on regular two week intervals during 
the studies and at the end of each project on live animals.  The mice were immobilized in 
a decapicone bag with slots for the hind limbs.  The medial aspects of the hind limbs 
were cleaned and blood was sampled from the saphenous vein via venipuncture.  Plasma 
was retrieved after cold centrifugation and individual samples (n=3) from each 
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experimental condition were pooled.  The blood sampled at the end of experiment was 
taken directly from the inferior vena cava.  These samples were allowed to clot at room 
temperature and were then centrifuged.  The serum was also pooled (n=3) based on 
common inclusion in a given experimental condition.  The pooled samples were extracted 
in ethyl acetate (Sigma Aldrich, St. Louis, MO) that was then evaporated.  The residue 
was re-suspended in steroid free serum (IBL America, Minneapolis, MN). 
 Testosterone (ng·ml-1) and 17β-estradiol (pg·ml-1) was measured via ELISA (IBL 
America, Minneapolis, MN) per the manufacture’s instructions.  The data were assessed 
for error and outliers and adjusted accordingly.  Data points with high variation between 
duplicate measures or considerable (one data point exceeded the other data points in the 
group by greater than 500%) deviation from the condition mean were eliminated from 
analysis.  Unfortunately, viable blood samples were not obtained from the female cohort, 
but vaginal smears and inspection of the uterine horns were completed to evaluate the 
effectiveness of each experimental intervention. 
 Statistical Analysis:  Distance, duration, and speed were averaged for seven days 
per experimental treatment (i.e. baseline, gonadectomized, and replaced).  Unpaired-
sample t-tests were utilized to evaluate the overall mean differences attributable to sex.  
Separate two-way (group by treatment) analysis of variance (ANOVA) calculations were 
used to assess differences between the treatment levels for each physical activity variable.  
A three-way ANOVA was used to compare the body composition measures between 
groups, sexes, and experimental periods.  Tukey’s HSD post-hoc tests were used if the 
main effects or interactions from the initial ANOVA reached significance.  The alpha 
value was set a priori to 0.05. 
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Results 
 Male Mice:  While no difference was noted between the treatment groups during 
the baseline period (i.e. before gonadectomy), physical activity patterns of the male mice 
were markedly altered by removal and replacement of the sex steroids (Figure 9).  After 
orchidectomy, both the testosterone and 17β-estradiol groups ran significantly less (10% 
of baseline, p<0.05) than the sham group and compared to baseline measurements.  
Replacement of testosterone recovered the activity pattern back to baseline and sham 
levels (90% of baseline).  Replacement of 17β-estradiol partially recovered running 
distance (31% of baseline), but the distance remained significantly less (p<0.05) than 
baseline and sham values.  Wheel running duration mirrored the distance results.  At 
baseline, running durations were similar among the different experimental groups.  
Orchidectomy significantly reduced (19% of baseline) daily running duration compared 
to the sham group and baseline values (p<0.05).  Testosterone replacement recovered 
duration to baseline levels (97% of baseline) while 17β-estradiol replacement failed to 
recover running duration to baseline levels (44% of baseline).  Average wheel running 
speed was significantly influenced (59% of baseline) by sex gland removal (p<0.001) and 
recovered to near baseline after replacement.  Running speed was significantly recovered 
during testosterone replacement (93% of baseline).  17β-estradiol replacement increased 
running speed to near baseline levels (74% of baseline), but did not recover running 
speed by the same magnitude as testosterone replacement. 
 Female Mice:  Without regard to the steroidal or surgical conditions of the mice 
(all female data points compared to all male data points), the females ran farther (t=3.87; 
p<0.001), longer (t=4.06; p<0.001), and faster (t=2.24; p<0.05) than their male 
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counterparts.  However, similar to the males, removal and replacement of the sex steroids 
altered the physical activity patterns of the female mice (Figure 10).  The female mice did 
not show differences in the running pattern among the experimental groups at baseline.  
As in the male mice, both the surgical and replacement interventions influenced running 
distances.  After ovariectomy, wheel running distance was partially reduced (31% of 
baseline, p<0.05); running activity was reduced less in females than males after surgery.  
Administration of testosterone fully recovered running distance (114% of baseline), while 
replacement of 17β-estradiol only slightly recovered running distance (43% of baseline).  
After removal of the ovaries, running duration was significantly reduced (37% of 
baseline, p<0.05).  Testosterone increased running time to the highest levels recorded 
during the experiment (103% of baseline).  After replacement of 17β-estradiol, wheel 
running duration remained significantly different compared to baseline values (46% of 
baseline, p<0.05).  Running speed was significantly reduced after removing the ovaries 
(79% of baseline, p<0.05) in the 17β-estradiol treatment group, but not in the testosterone 
group (85% of baseline).  Testosterone administration increased (107% of baseline) 
running speed slightly above the baseline and sham values.  Replacement with 17β-
estradiol slightly (86% of baseline) increased running speed. 
 Body Composition:  The body mass (g) and body fat (%) measures are 
summarized in Table 3.  The body masses varied between sexes and across the 
experimental periods.  Males (25.1±1.9) weighed significantly more then females 
(20.9±2.0) throughout the study.  The body mass increased significantly across all three 
periods (baseline: 21.8±2.9; after gonadectomy: 22.5±2.3; with replacement: 25.0±2.6).  
The percentage of body fat was also altered across experimental periods; percentage body 
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fat was significantly lower during replacement (11.14±0.90) compared to baseline 
(14.13±2.04) and gonadectomy (13.11±1.20). 
 Implant Efficacy:  The functionality of silastic implants to deliver sex steroids in 
rodents has been previously shown and is a common technique in the endocrinology 
literature (11, 17, 20, 25, 36, 91, 99).  Direct measurement of sex steroid blood plasma 
levels in the mice observed during study is difficult due to the necessary volume 
restrictions placed on survival blood draw techniques.  Viable blood samples were 
obtained from male mice and ELISA data were summarized in Table 4.  Plasma 
testosterone decreased after gonadectomy and 17β-estradiol remained about the same.  
With testosterone administration, both testosterone and 17β-estradiol levels were elevated 
to levels above the levels observed at baseline.  Administration of 17β-estradiol did not 
affect testosterone levels, but dramatically increased plasma 17β-estradiol levels.  The 
function of the implants and surgical success were confirmed via several direct 
observations in the female mice.  First, the female mice receiving implants presented with 
visibly larger uterine horns when compared to control animals, suggesting circulating 
steroids were present in these mice (42).  Secondly, the content of vaginal smears taken 
from individuals with steroid implants, were dominated by the presence of cornified 
epithelial cells, which also are indicative of estrogen replacement (42).  Thirdly, the 
vaginal content of the mice after gonadectomy, but prior to implantation of silastic 
capsules was void of cellular debris.  Thus, the successful use of silastic implants by past 
researchers to deliver steroid compounds to rodents (17) and the direct observations made 
during this study suggest effective delivery of 17β-estradiol and testosterone to the 
present cohort of mice. 
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 In addition to the aforementioned observations, semi-quantitative measures of 
steroid release were made.  Each implant contained approximately 3600 μg of powder 
steroid prior to placement in a mouse.  Accurate post usage measurement of steroid 
containing devices is difficult due to the absorption of extraneous bodily fluids as the 
steroid moves into circulation.  With the use of the current method of steroid delivery it 
was evident through direct observation that during the seven day period approximately 
half (1800 μg) of the powder had exited the implant upon retrieval of the capsule from 
the mice.  Based on these observations it was estimated that between 200 and 300 μg was 
released from the capsules per day over the seven-day period.  Comparing these data to 
the data of Cohen and Milligan (17), the capsules used in this study induced supra-
physiological levels of the steroid in circulation as these authors demonstrated a five-fold 
increase in vaginal smear response and a nine-fold increase in uterine weight after an 
eight day exposure to silastic capsules containing 17β-estradiol (100 μg·ml-1).   This 
method of steroid delivery was chosen to ensure adequate delivery of the steroids into the 
blood and the tissues involved in activity regulation.  It has previously been shown that 
the blood plasma levels of the sex steroids are not equal to the levels of the steroids found 
in other tissue areas including the brain (37). 
Discussion 
 In this study, running distance, duration, and speed were significantly reduced 
following surgical removal of the gonads in male and female C57BL/6J inbred mice.  
After the diminution of wheel running activity, attempts to recover activity levels via 
exogenous testosterone and 17β-estradiol produced variable magnitudes of recovery.  
Testosterone’s propensity to boost the activity pattern in mice to normal levels after 
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gonadectomy (101% of baseline; average across all wheel running indices) was evident in 
both males and females and surprising given the limited and contradictory (114) literature 
available regarding testosterone replacement.  As surprising, were the somewhat limited 
effects of administered 17β-estradiol which resulted in only partial recovery of the 
activity patterns of both sexes (54% of baseline; average across all wheel running 
indices).  Interestingly, the present study indicates that both testosterone and 17β-
estradiol influenced activity primarily by modulating running distance and duration as 
opposed to speed.  Thus, while administration of estrogens has been shown previously to 
recover activity levels to some extent (43), these are the first data to suggest an equal or 
higher activity recovery level with testosterone administration. 
 Running Wheel Activity:  This study evaluated physical activity patterns as a 
multifaceted character because running duration and speed have not been investigated in 
the previous sex steroid related literature.  These physical activity indices have been 
suggested to contain a significant genetic component (77, 83) but the mechanisms are yet 
to be fully delineated.   Given that the treatment we used was replacement of the sex 
steroids, the design of the present study allowed for further understanding of the 
interactions of the sex steroids and these physical activity indices.  The novel aspect of 
the current study is that it examined both sexes under individual influences of both an 
estrogenic and androgenic compound via gonadectomy and replacement procedures. 
 The majority of activity studies present in the literature have used number of 
wheel revolutions or running distance (revolutions multiplied by wheel circumference) to 
evaluate changes to physical activity patterns and have mostly reintroduced estrogen 
analogs after sex gland removal.  Gorzek et al. (43), who observed a decrease from 
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roughly 9.0 km·day-1 to less than 1.0 km·day-1 in a group of female C57BL/6J mice after 
ovariectomy and  Hoskins, in 1925 (54) who observed a decrease from 15,142 rev·day-1 
(≈ 14.6 km·day-1) in normal male rats to 3,283 rev·day-1 (≈ 3.2 km·day-1) in castrated 
male rats are just two examples of studies that have observed decreases in activity with 
removal of the sex steroids. 
 The preponderance of literature in this area has investigated the effect of 
estrogenic replacement on wheel running with some variability in post-surgical recovery 
of activity.  Most recently, Gorzek et al. (43) observed recovery of wheel running activity 
to levels observed in control mice (≈ 85% compared to shams) of running distance in 
female mice with administered 17β-estradiol.  Durrant (22) fed ovariectomized white rats 
a diet of glycerine prepared ovarian extracts and reported no effects on wheel revolution 
number suggesting limits to activity recovery with oral administration of steroids.  Wang, 
Richter, and Guttmacher (144) demonstrated a robust increase from less then 1,000 
rev·day-1 to between 6,000 and 8,000 rev·day-1 in castrated male rats treated with ovarian 
tissue grafts from female littermates.  This response equated to a 50-100% recovery 
compared to intact control animals.  Bugbee and Simon (15) found 100% of wheel 
revolutions were recoverable with repeated injections of ovarian follicular fluid, but 
noted that when the dosage was tripled, additional improvements in activity were not 
observed.  The designs and age of past experiments have made it difficult to determine 
dose responses and thus, it is unclear how the estrogen replacement dosages used in 
previous literature compare to that used in the current study.  However, the various 
estrogen replacement protocols in the literature have resulted in a 50-100% recovery rate 
for activity with the lower recovery rates reported by these studies (15, 22, 43, 144) 
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similar to those observed in the present study. 
 Potential Androgenic Effects:  There are few studies regarding the androgenic 
influences on activity patterns in rodents available for comparison with the results of the 
current study.  Before the discovery of testosterone, Hoskins (55) grafted testicular tissue 
into castrated rats, but did not observe changes in their activity patterns.  In a similar 
study, Richter and Wislocki (110) used a more elaborate technique to introduce testicular 
grafts into male and female rats.  The authors found a greater number of wheel 
revolutions in several of the animals and upon further histological investigations 
suggested that successful transplantation of the grafted tissue in most animals resulted in 
running at higher levels.  Much later, Roy and Wade (114) investigated the effects of 
aromatizable testosterone propionate and found increased activity (from 2 km·day-1 to 4 
km·day-1) in castrated male rats.  To our knowledge, the data in the current study 
represent the first data available regarding the effect of testosterone replacement on 
activity patterns in both male and female mice and suggests that testosterone may play a 
larger role in regulating daily activity than previously suggested.  Thus, our results 
suggest a broader picture of physical activity regulation by the sex steroids that also 
includes a yet to be outlined androgenic effect. 
 There are three lines of evidence commonly reported to support involvement of 
estrogen rather than testosterone compounds as the primary activity regulator in rodents.  
First, several experiments have shown a variable increase in activity in both male and 
female rodents when estrogenic compounds are delivered through a variety of 
administrative techniques (6, 15, 43, 107, 108, 120, 121, 141-144).  Second, in studies of 
knockout mice of both sexes, Ogawa et al. (92) observed that activity levels were 
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dependent upon an interaction between an estrogenic compound and estrogen receptor α.  
In their study, no differences in activity were seen after implantation of β-estradiol 3-
benzoate in animals lacking the α isoform of the estrogen receptor.  Third and most 
notable, Roy and Wade (114) observed increased activity patterns only with the 
administration of testosterone propionate, an aromatizable androgen and not with 
administration of dihydrotestosterone propionate, a non-aromatizable androgen in 
castrated rats (114). 
 The mice in the present study that received 17β-estradiol capsules after 
gonadectomy would have elevated levels of the estrogens alone (Figure 11).  Since the 
estrogens are not converted to testosterone, very little testosterone would be present in 
these mice.  The mice receiving testosterone implants would fall into one of three 
categories regarding steroid levels in general circulation; 1) only estrogens are present 
(complete conversion of testosterone to estrogens via aromatization; Figure 11, panel a), 
2) some of each steroid is present (some testosterone is aromatized to estrogens; Figure 
11, panel b), and 3) only testosterone is present (no conversion to estrogens via 
aromatization; Figure 11, panel c). 
 Comparisons between the estrogen replacement group and the testosterone 
replacement groups mentioned above (no estrogen, some estrogen, all estrogen) suggest 
the presence of an androgenic regulatory effect on physical activity (Figure 11).  The 
precise dimensions of a silastic implant allowed a constant volume (approximately 200 to 
300 μg·day-1 as suggested earlier) of steroid to be present in each capsule, which led to 
the release of similar amounts of steroids to all mice.  Therefore, the circulating levels of 
estrogens in mice with 17β-estradiol capsules would be equal only to the levels of mice 
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with testosterone capsules if the testosterone were converted completely to 17β-estradiol 
leaving no circulating testosterone (Figure 11, panels a, d, g).  If the testosterone were 
completely converted to 17β-estradiol, it should be expected that the mice, regardless of 
steroid replaced, would not differ in activity performed.  This was not the case in this 
study, as the mice receiving the testosterone capsules out performed the mice receiving 
the 17β-estradiol capsules.  In reality, replaced testosterone is probably not entirely 
converted to 17β-estradiol (Figure 11, panel b).  The residual levels of testosterone 
remain available to interact in an androgenic manner that can affect activity levels.  These 
observations conflict with the results of Roy and Wade (114) who suggested that the 
androgens needed to first be converted to estrogens prior to influencing wheel running; 
we observed that testosterone’s regulatory effects were not dependent upon estrogen. 
 Other Potential Effect Factors:  The removal of the gonads, especially in female 
mice, not only removes the primary estrogen sources in these animals, but also a 
substantial progesterone source.  While the influence of progesterone on wheel running 
activity was not the focus of this paper, past research has indicated a minimal effect of 
this steroid on activity regulation.  Rodier (111) injected ovariectomized albino rats with 
40 mg·kg-1·day-1 progesterone and found no changes to the activity pattern.  In the same 
study, 8 mg·kg-1·day-1 of progesterone was given to intact female rats and was found to 
have a slight inhibitory effect (111).  Based on these lines of evidence, the effects of 
progesterone loss due to ovariectomy in the present study was likely minimal. 
 The changes observed in the body composition variables appear to relate to 
natural differences between the sexes and appeared to follow temporal patterns rather 
than patterns attributable to changes in steroid status.  Past research (45) has shown 
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changes in body composition characteristics with alterations in steroid levels; however, 
the brevity of the experimental periods in this study may have hindered full development 
of this effect.  Furthermore, the effects of body mass on activity have been shown to be 
limited in non-obese rodents (32, 82, 136). 
 In conclusion, the current study investigated the influence of both testosterone and 
17β-estradiol on physical activity patterns in male and female C57BL/6J mice.  All three 
indices of activity were significantly decreased with removal of the sex steroids; running 
distance and duration were most responsive to alterations in circulating steroid levels.  
The differences in recovery of physical activity observed in mice implanted with 17β-
estradiol (lower recovery) and testosterone (higher recovery) provided evidence that in 
mice, both steroids variably alter activity patterns.  Based on the significantly larger 
magnitude of recovery with testosterone replacement, it is suggested that testosterone—
believed from limited past studies to only regulate activity via an estrogen dependent 
mechanism—may also influence activity through a direct, androgenic mechanism. 
 
 
61 
Acknowledgments:  The project described was supported by NIH NIAMS AR050085 
(J.T. Lightfoot, R.S. Bowen, A.M. Knab, A.T. Hamilton, T. Moore-Harrison).  The 
authors would like to thank the UNC Charlotte Vivarium staff for assistance with animal 
husbandry needs. 
Footnotes: 
Authors:  Robert S. Bowen1, Amy M. Knab1, Alicia Trynor Hamilton1, Jennifer A. 
Rettew2, Trudy Moore-Harrison1, J. Timothy Lightfoot1 
1Department of Kinesiology, University of North Carolina Charlotte, Charlotte, NC 
28223 
2Department of Biology, University of North Carolina Charlotte, Charlotte, NC 28223 
Journal Submission: At the time of publication of this dissertation, the following 
chapter was in review for publication in the journal: Physiology & Behavior 
 
 
62 
 
 
Figure 8.  Experimental timeline (in days) for study assessing physical activity 
differences in C57BL/6J mice under various circulating sex steroid levels including 
normal physiological levels at baseline, low levels during gonadectomy phase, and 
elevated levels during replacement phase.  Baseline, gonadectomy, and replacement were 
the experimental periods for this project. 
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Figure 9.  Male C57BL/6J mice wheel running distance, duration, and speed under 
normal physiological condition (Baseline), with low circulating steroid levels 
(Gonadectomy), and with artificially elevated steroid levels (Replacement).  White 
bars=sham controls; Hatched bars=testosterone during replacement period; Black 
bars=17β-estradiol during replacement period; *=significantly different from sham 
controls and baseline treatments. 
 
 
64 
 
Figure 10.  Female C57BL/6J mice wheel running distance, duration, and speed under 
normal physiological condition (Baseline), with low circulating steroid levels 
(Gonadectomy), and with artificially elevated steroid levels (Replacement).  White 
bars=sham controls; Hatched bars=testosterone during replacement period; Black 
bars=17β-estradiol during replacement period; *=significantly different from sham 
controls and baseline treatments; †=significantly different from baseline. 
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Figure 11.  Schematic representation comparing mice receiving only 17β-estradiol 
(represented by mouse with ‘E’ on abdomen) to those receiving testosterone (represented 
by mouse with ‘T’ on abdomen) after surgical gonadectomy.  Three scenarios (panels a-
c) exist regarding testosterone’s conversion and lead to three possible wheel running 
responses if the estrogens are the primary effecters of activity (panels d-f) and three 
possible responses if an androgenic effect is also present (panels g-i).  T=Testosterone, 
E=17β-estradiol, dotted outline=observed outcome from present dataset. 
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Table 4.  Sera/plasma testosterone and 17β-estradiol concentrations for 
mice* at baseline and under various placebo and experiment conditions 
Condition (n=T/E2) Testosterone (ng·ml-1) 
mean±SD 
17β-Estradiol (pg·ml-1) 
mean±SD 
Baseline (n=3/3) 6.32±2.79 59.82±16.72 
Placebo (n=15/15) 11.53±7.54 397.08±881.50 
Experimental 
ORCH (n=3/2) min 109.79±29.71 
ORCH+E2 (n=2/3) 0.21±0.23 613.44±185.90 
ORCH+T (n=3/2) 15.37±1.21 151.96±53.20 
*Sera/Plasma from 3 mice were pooled together 
Abbreviations: ORCH=Orchidectomy, E2=17β-Estradiol Implant, 
T=Testosterone Implant, min=at the minimum of prediction curve 
 
 
CHAPTER 3: 
EFFECTS OF AROMATASE INHIBITION ON THE PHYSICAL ACTIVITY LEVELS 
OF MALE MICE 
 
 
Abstract 
 Increasing activity levels in an inactive population can lead to associative 
increases in health and well-being.  Both biologic and genetic factors have been identified 
that alter activity levels in humans and rodents.  Currently, it is suggested that the 
androgens require conversion to estrogens prior to eliciting any effects on activity 
patterns.  Recent data contradicts this assertion; thus, the purpose of this study was to 
evaluate the necessity of the aromatase complex in activity regulation.  Wheel running 
was assessed in male C57BL/6J mice (n=80) under various sex steroid-disrupted and 
aromatase-inhibited conditions.  Silastic capsules and surgical orchidectomies were used 
to alter circulating sex steroid levels.  Inhibition of the aromatase complex was achieved 
through administration of an irreversible aromatase inhibitor.  Wheel running was 
unaffected (p>0.05) by aromatase inhibition in reproductively intact and sex steroid 
supplemented mice.  Orchidectomy significantly (p<0.05) reduced wheel running 
activity.  Steroid replacement recovered wheel running to pre-surgical levels; however, 
aromatase inhibition did not affect wheel running levels (p>0.05).  The persistence of 
wheel running in mice with compromised aromatase function suggests that the 
androgens—testosterone in particular—may directly affect wheel running patterns in 
male mice.
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Introduction 
 Physical inactivity affects public health and unnecessarily burdens the American 
health care system.  The risks of many diseases including obesity, diabetes, heart disease 
and several types of cancer are enhanced in individuals with habitually low physical 
activity levels (87).  Although evidence exists suggesting that activity levels are 
determined by extrinsic and environmental factors, a growing number of literature 
sources suggest large genetic and biological influences also exist (63, 70, 77, 82, 83, 
131).  Androgens and estrogens have been the focus of extensive research relating to 
activity levels in rodents and the loss of testes or ovaries results in noted reductions in 
daily wheel running activity (43, 57, 81, 90, 92). 
 Currently, testosterone is suggested to require prior conversion to an estrogenic 
compound before any modulatory interactions to the wheel running response will occur.  
Roy and Wade (114) administered aromatizable and non-aromatizable forms of 
androgens to orchidectomized rats.  The aromatizable androgen notably increased wheel 
running, but administration of the non-aromatizable molecule resulted in continued 
quiescence. 
 Supporting Roy and Wade’s earlier study, Watai et al. (145) found that wheel 
running activity was hindered in an estrogen-deficient aromatase knockout mouse model.  
Conversely, Hill et al. (49), using a similar aromatase knockout model found that, the 
male knockout animals ran nearly twice as far as wild type animals, an observation that 
was reversed in three weeks with the administration of 17β-estradiol. While the use of 
knockout animals can lead to difficulties with interpretation due to issues arising during 
development due to the lack of the knocked out gene (16), it is interesting that the two 
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studies using aromatase knockout animals resulted in completely opposite results. 
 Thus, other experimental methods, such as the use of aromatase-inhibiting 
substances to circumvent the issues related to the use of knockout animals, is warranted 
for further elucidation of the roles of the sex steroids in physical activity regulation.  With 
this approach, the functionality of particular physiological pathways can be altered 
without hindering normal development.  The purpose of this study was to evaluate wheel 
running activity in the presence of irreversible and reversible aromatase inhibitors under 
normal physiological conditions and during artificial manipulation of endogenous sex 
steroid levels in male mice. 
Methods 
 Animals:  Eighty male C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) 
were used in three experimental procedures starting at approximately 63 days old.  All 
mice were housed in an environmentally controlled animal husbandry facility under 
12/12 h light/dark cycles with lights illuminating the housing room at 6:00am daily.  
After arrival at the research facility, mice were initially housed with six to eight 
littermates prior to initiating an experimental protocol.  After acclimation and at 
approximately eight weeks of age (≈54 days old), the animals were individually housed 
in standard rat sized cages with metal running wheels during each experiment.  The cages 
were equipped with a stainless metal food hopper and glass water bottle.  The mice were 
allowed ad libitum access to both food and water.  This project conformed to the ethical 
standards set forth by the scientific community and was approved by the UNC Charlotte 
Institutional Animal Care and Use Committee prior to initiation. 
 Wheel Running:  Running wheels (450 mm circumference; Ware Manufacturing, 
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Phoenix, AZ) with a 40 mm wide running surface were attached to the metal tops of each 
cage and were equipped with cycling computers (BC500, Sigma Sport, Olney, IL) to 
track wheel running distance (km) and duration (min).  Average speeds (m·min-1) for 
each day of analysis was calculated by dividing distance by duration.  Each experimental 
epoch lasted seven days and wheel running data was collected every 24 hours.  Average 
daily distance, duration, and speed were calculated for each seven day experimental 
epoch.  Seven days of data were used in calculating each average for the epoch unless the 
recording computer was found non-functional.  These data were removed from the 
calculation and the average was derived from five to six data points.  Each computer was 
calibrated to the running wheel’s circumference and was checked for proper connectivity 
on a daily basis by a research technician.  Furthermore, the freeness of the wheel’s 
rotation about the axle was checked daily and lubricated as needed.  The wheels were 
sanitized every two weeks for the length of the experiments and were brushed when 
needed to keep the running surface free of debris (bedding, food, feces, etc.). 
 Injections:  During this study, control and experimental injections were 
administered.  Control injections consisted of 0.3% hydroxypropyl cellulose in phosphate 
buffered saline (HPC+PBS) and was administered in a 0.5 ml subcutaneous bolus.  
Experimental injections contained the aromatase inhibiting substance exemestane 
(Sigma-Aldrich, St. Louis, MO) suspended in HPC+PBS.  The drug was administered 
subcutaneously at a dosage of 250 mg·kg-1 per 0.5 ml bolus.  This dose schedule was 
developed to yield maximum inhibition of aromatase activity (44, 61).  Prior to 
administration, steps were taken to maintain the sterility of the injection medium by using 
a standard liquid autoclave cycle prior to storage in a sterile lab container.  The 
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exemestane was dissolved in methanol and passed through a 0.2 micron cellulose filter 
into a sterile mortar to remove impurities in the drug.  The methanol was then evaporated 
and the residue exemestane was ground and added to an aliquot of sterile HPC+PBS to 
form a dispensable suspension for injection. 
 Alterations of Sex Steroid Levels:  To vary the levels of circulating steroids, two 
procedures were employed.  First, supplementation or replacement of steroids was 
achieved via silastic (Dow Corning, Midland, MI) implants.  Testosterone and 17β-
estradiol (Sigma-Aldrich, St. Louis, MO) were packed into 10 mm lengths of 1.02 mm 
internal diameter silastic tubing.  The ends of the tubing were capped with clear silicone 
glue.  The placebo implants were left empty.  The implants were surgically inserted under 
isoflurane anesthesia in a small subcutaneous pocket on the lateral aspect of the neck 
between the skin and the muscle fascia.  A two day recovery was allowed prior to 
reintroduction of running wheels. 
 The second technique for altering the levels of circulating steroids was the 
completion of bilateral orchidectomy surgeries to remove the testes, the major sex steroid 
producing tissue in male mammals.  The surgeries were performed under isoflurane 
anesthesia after administration of the preemptive analgesic carprofen (5 mg·kg-1).  A 
small incision was made in the midline of the scrotum just inferior to the penis.  Each 
testis was exposed through the incision and was removed along with the epididymis.  The 
incision was closed with a sterile wound clip and the animal was allowed to recover 
under a heating lamp.  Placebo animals received a sham procedure; the testis were 
exposed but were not excised.  The surgical procedures were followed by ten days of 
wheel free recovery. 
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 Experimental Procedures:  The experimental timeline for each experiment is 
shown in Figure 12.  Twenty mice were used in the first experiment.  Mice, stratified by 
original group housing, were randomly assigned to a placebo (n=10) or experimental 
(n=10) group.  In both groups, wheel running was monitored under three conditions.  
First, both groups underwent baseline screening for seven days to assess normal 
physiologically wheel running activity.  Next, each mouse received either placebo or 
exemestane injections and wheel running was monitored for an additional seven days.  
Lastly, injections ceased and mice were allowed three days of unmonitored wheel 
running followed by a final seven days to assess wheel running during drug clearance. 
 Thirty mice were used in experiment two to evaluate the effects of supplemented 
sex steroids on wheel running activity during exemestane injections in mice with fully 
functional reproductive organs.  One mouse was euthanized at the onset of the 
experiment due to an injury sustained during the preliminary group housing phase.  The 
mice were divided into control (n=9), experimental one (n=10), and experimental two 
(n=10) groups.  Wheel running was again assessed at baseline under normal 
physiological conditions for seven days.  During the next seven days of wheel running 
activity, the mice received exemestane (experimental one and two) or placebo (control) 
injections.  In the final seven days of this experiment, the mice received silastic implants 
containing testosterone (experimental one) or 17β-estradiol (experimental two).  The 
control animals received empty implants.  After a brief two day recovery, exemestane 
and control injections were resumed and wheel running was evaluated for seven 
additional days. 
 The third experimental procedure utilized thirty mice and evaluated the effects of 
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orchidectomy and aromatase inhibition on wheel running activity.  Replacement 
strategies (via silastic implants) were employed to reintroduce the sex steroids after 
removal of the gonads.  The experimental groupings were as stated above in experiment 
two.  Baseline data was collected at the onset of the experiment.  Double and sham 
orchidectomies were performed and were followed by a ten day recovery period.  Wheel 
running was evaluated at the end of the orchidectomy recovery period for seven days and 
then continued for seven more days while placebo or exemestane injections were 
administered every 24 hours.  Silastic implant surgeries were performed followed by two 
days of recovery and a final seven day wheel running assessment period.  Testosterone, 
17β-estradiol, and blank implants were again utilized during this final period. 
  Blood Collection and Sex Steroid ELISAs:  The present study was conducted in 
close succession with two additional projects with similar placebo and experimental 
conditions; thus, blood was sampled throughout these experiments, stored, and assayed 
conjunctively.  Blood was sampled on regular 14-day intervals via venipuncture and 
directly from the inferior vena cava at the time of sacrifice.  Each mouse was restrained 
in a decapicone bag with openings to expose the hind limbs.  The medial surface of the 
exposed limbs were shaved and cleaned.  The saphenous vein was exposed through 
application of light pressure to the proximal segment of the hind limb and was punctured 
using a 25 gauge sterile needle.  The blood was collected into EDTA or heparinized 
microvette capillary tubes and stored on ice for up to three hours.  Plasma was separated 
from the red cell mass via cold centrifugation and was stored until assay.  Samples 
collected at the end of the experiments were allowed to clot and were then centrifuged at 
room temperature.  The serum was stored until assay. 
 
 
75 
 Sera/plasma samples (n=3) were pooled together based on the experimental 
condition at the time of collection.  An extraction procedure was performed on the pooled 
samples prior to assay.  Pooled samples (200 μl) were combined with 1000 μl of ethyl 
acetate (Sigma-Aldrich, St. Louis, MO) and were frozen over night.  The ethyl acetate 
was then decanted and evaporated.  The dry, extracted residue was reconstituted in 
steroid free serum (IBL-America, Inc., Minneapolis, MN) and was used in all assay 
procedures. 
 Testosterone and 17β-estradiol concentrations were measured via ELISA (IBL-
America, Inc., Minneapolis, MN).  Calibrator samples were used to estimate the 
concentration of the unknown samples.  All samples were measured in duplicate and the 
average value was used as each samples’ concentration.  A data point was eliminated 
from analysis if duplicate measurements were highly variable or if an individual 
concentration was different (500% difference between a single data point compared to 
other data points in the group 500%) from the group mean. 
 Letrozole Experiment:  Exemestane has both aromatase inhibiting and androgenic 
properties.  It was speculated that the effects from the first three experiments utilizing 
exemestane might be due to the androgenic rather than the aromatase inhibiting effects; 
therefore, the reversible aromatase inhibitor letrozole (Fisher Scientific, Pittsburgh, PA) 
was used to validate the results achieved in experiment one of the current project.  
Twenty untreated C57BL/6J mice were used in the confirmatory study and the 
methodological techniques were identical to experiment one.  In brief, placebo (n=10) or 
letrozole (n=10) injections were given to reproductively intact mice.  Wheel running 
indices were monitored prior to injections, during injections, and after cessation of 
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injections—each phase lasting seven days.  Letrozole was administered via sub-
cutaneous injections at a concentration of 0.5 μg per 100 μl of 0.3% HPC+PBS for seven 
days.  Placebo injections consisted of 0.3% HPC+PBS. 
 Statistical Analysis:  The physical activity data collected during each of the four 
experiments were analyzed using individual two-way (group by condition) analysis of 
variance (ANOVA) tests for each wheel running indices (distance, duration, or speed).  A 
Tukey’s post-hoc test was used to assess significant main effects or interactions.  The 
ELISA data for all experiments were assessed by one-way (condition) ANOVA.  The 
alpha level was set a priori at 0.05. 
Results 
 Physical Activity:  Wheel running indices (experiment one) for male C57BL/6J 
mice at baseline, receiving exemestane or placebo injections, and during a 10-day 
clearance period are shown in Figure 13.  The aromatase blocking substance was not an 
effective inhibitor of activity and did not significantly alter any of the wheel running 
indices at the administered dosage (250 mg·kg-1).  Distance (p=0.61), duration (p=0.38), 
and speed (p=0.69) did not change with exemestane injections.  The power values for 
these analyses were low (distance: power=0.10, duration: power=0.07, duration: 
power=0.15). 
 Running distance, duration, and speed for experiment two are shown in Figure 14.  
Wheel running was assessed at baseline, with exemestane injections, and after 
implantation of testosterone or 17β-estradiol containing capsules.  The difference across 
experimental conditions and groups were non-significant (distance: p=0.66, duration: 
p=0.61, speed: p=0.56 ) and neither testosterone nor 17β-estradiol altered the running 
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response.  Power values for these analyses was low (distance: power=0.19, duration: 
power=0.21, speed: power=0.23). 
 Wheel running indices (experiment three) at baseline, after surgical or sham 
orchidectomies, with placebo, testosterone, or 17β-estradiol implants, and with injections 
of placebo vehicle or exemestane are shown in Figure 15.  Wheel running was 
significantly altered by these experimental interventions (distance: F=4.65, p=0.0001, 
duration: F=4.82, p=0.0001, speed: F=6.63, p=0.0001) and Tukey’s HSD post-hoc tests 
revealed that several interventions altered the three wheel running activity indices 
measured (see Figure 15).  Orchidectomies significantly reduced all three indices of 
wheel running and testosterone replacement recovered wheel running back to baseline 
levels; however, 17β-estradiol failed to engender the same level of recovery.  
Administration of exemestane had limited effect on activity in the orchidectomized 
mouse receiving either steroid. 
 Testosterone and 17β-Estradiol ELISAs:  Testosterone and 17β-estradiol levels 
assessed in pooled sera/plasma samples across all three experiments in the present project 
are displayed in Table 5.  The testosterone and 17β-estradiol concentrations were highly 
variable, but not statistically different among the various conditions.  The widely 
different mean concentrations however, indicate very different endocrinological 
functionality among the conditions. 
 Letrozole Experiment:  Wheel running distance for control and letrozole-treated 
mice are displayed in Figure 16.  The wheel running response under this reversible 
aromatase inhibitor was similar to the response observed with exemestane inhibition.  All 
wheel running parameters were unaffected by letrozole administration and did not deviate 
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from the levels measured in the control animals (p>0.05). 
Discussion 
 The present results demonstrated that activity remains primarily unaffected by the 
administration of aromatase inhibitors in a dosage previously shown to maximally inhibit 
the aromatase complex (44, 61).  This project evaluated two manipulative strategies: 1) 
supplementation of both testosterone and 17β-estradiol in intact mice receiving the 
aromatase inhibitors; and 2) replacement of testosterone and 17β-estradiol in 
orchidectomized mice receiving the aromatase inhibitor.  Surprisingly, the results of this 
study demonstrate that the hypothesis of a primary estrogen-derived activity regulating 
mechanism is probably incorrect.  However, we are cautious in our conclusions due to the 
high variability in sex steroid concentrations observed in this study, which may mask the 
complete delineation of the mechanisms of sex steroid derived activity regulation in 
mice. 
 Aromatase Inhibition and Physical Activity Levels:  A physiologically normal 
C57BL/6J mouse runs vigorously when exposed to an in-cage running wheel.  
Alterations to the sex steroids interrupt this normal running pattern (54, 56, 106, 144), an 
effect expected to occur through modulation of estrogen levels via the aromatase complex 
based on previous research (114).   However, in the current project, inhibition of the 
aromatase complex did not significantly alter wheel running activity indicating that a 
functional aromatase complex may not be required for activity levels to be modulated.  
While contradictory to previous speculations, little direct evidence exists that indicates 
activity regulation—via the sex steroids—requires the presence of estrogenic compounds. 
  Roy and Wade (114) assessed the ability of testosterone propionate (an 
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aromatizable androgen) and dihydrotestosterone propionate (a non-aromatizable 
androgen) to affect activity levels in castrated male rats.  Administrations of the 
aromatizable androgen increased activity to the levels observed in estrogen treated 
animals, but the non-aromatizable androgen had little effect (114).  In addition, changes 
to wheel running levels were also different.  Roy and Wade (114) noted a partial recovery 
of wheel running with testosterone administration compared to estradiol benzoate 
administration.  In the current study, wheel running not only returned to the levels 
observed at baseline, but exceeded the levels induced by 17β-estradiol administration.  
This difference maybe accounted for by the modes of steroid delivery used in each 
project.  The steroidal compounds were delivered via silastic implants in the current 
project, but Roy and Wade (114) delivered the steroids via daily injections in sesame oil.  
The injection methods employed by Roy and Wade (114) required daily contact with the 
animals which has been shown to induce higher levels of stress and changes to wheel 
running activity (104).  The effects of human interaction on wheel running behavior 
observed by Richter (104) were not as dramatic as the differences noted between Roy and 
Wade (114) and the current project; therefore, other mechanisms may also be influencing 
the activity patterns in the current study.  Unfortunately, steroid concentrations were not 
quantified by Roy and Wade (114); therefore, further direct comparison is difficult. 
 Watai et al. (145) evaluated activity in an aromatase (Cyp19) knockout mouse 
model and observed very low activity levels in these mice noting a requirement for 
estrogens to be present in order for activity levels to match those observed in normal 
animals.  The use of gene knockout models are not without adversity as developmental 
differences in mice can result in an obscured representation of reality (16).  The 
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difference between the current study and Watai et al. (145) may be due to such effects 
and thus, may be due to a abnormal physiological phenomenon rather than relevant 
deviations in the mechanisms affecting activity levels. 
  Hill et al. (49) evaluated wheel running activity in estrogen deficient male mice, 
similar to the mice utilized by Watai et al. (145) and observed compulsory wheel running 
activity that exceeded the levels observed in wild type controls.  Interestingly, this effect 
was not observed in female Cyp19 knockout animals and compulsory wheel running was 
ameliorated after the administration of 17β-estradiol (49).  The non-essential need for a 
functional aromatase complex to maintain normal activity levels observed in the present 
study and by Hill et al. (49) is contrary to the observations of Roy and Wade (114) and 
Watai et al. (145).  The technical difference noted in these studies may account for some 
of the observational disparities; however, further study detailing the underlying 
estrogenic and androgenic mechanisms is required. 
 Potential Androgenic Mechanisms of Activity Regulation:  The presence of an 
activity modulating mechanism regulated by androgenic steroids remains unclear with 
minimal supporting data in the literature.  The current study suggests that, at a minimum, 
an androgenic mechanism of activity regulation exists in mice.  Two primary lines of 
evidence from the current project support the hypothetical presence of an androgenic 
activity regulator.  First, blockade of the aromatase complex via either reversible or 
irreversible aromatase inhibiters did not significantly reduce wheel running in 
reproductively intact or sex steroid treated orchidectomized mice.  Second, testosterone 
replacement to orchidectomized mice increased wheel running activity back to baseline 
levels, while 17β-estradiol increased wheel running to only 50% of baseline levels 
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despite higher concentrations of estrogens levels in the 17β-estradiol treated animals. 
 The current research represents the second attempt to evaluate a direct androgenic 
mechanism in non-genetically modified mice.  Flynn et al. (29) exposed mice to the 
antiandrogenic fungicide vinclozolin at gestational age seven in dam’s milk and 
continued exposure via food after weaning.  With exposure to vinclozolin, both males 
and females exhibited decreased wheel running levels; however, only the females reached 
a statistically significant decrease in wheel running activity at the highest dose of the 
chemical.  The authors (29) concluded that the depressive effects of vinclozolin on 
activity levels were caused by an inhibitory interaction between the fungicide and the 
androgen receptor.  Thus, the data of Flynn et al (29) partially supports our hypothesis 
regarding the existence of an androgenic physical-activity regulating mechanism. 
 While several authors (18, 37, 53, 66, 140) have identified high malleability of the 
activity response in animals treated with estrogens directly to the brain, the permeability 
of the rodent brain to androgens is also high (94) suggesting a potential pathway for 
testosterone to effect a central activity regulator.  To date, only one paper (50) has 
evaluated brain morphology in aromatase compromised mice.  Hill et al. (50) noted lower 
levels of dopaminergic neurons in the medial preoptic area and arcuate nucleus of male 
knockout mice.  This response would tentatively explain their noted increased activity 
levels of the aromatase knockout mice based on recent work from Knab et al. (70) that 
suggested an increased activity level was due to down-regulated dopamine 1 receptor 
levels; i.e. the animals were more active to drive the reward signaling from the dopamine 
receptors higher.  Thus, we can speculate that testosterone influences activity levels in 
male mice through interactions with the androgen receptor leading to alteration of central 
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dopamine function. 
 Study Limitations:  The periodic measurement of sex steroids from the same 
mouse over a matter of weeks, as was completed in this project, is very difficult.  The low 
plasma/sera volumes obtained from an individual mouse are often too small for 
assessment of sex steroid concentrations in each mouse using any known assay 
procedure.  In this project, this issue was circumvented with pooling techniques that 
allowed the samples for a given experimental condition to be increased to an appropriate 
volume for assay detection.  However, the errors extending from the pooling technique 
are limited by the use of genetically identical mice.  Thus, the variations observed in 
hormone concentrations were due to environmental sources and the experimental 
manipulation rather than inherent difference in steroid levels between mice. 
 The blood sampling techniques employed in this project required close contact 
with the mice on the day of blood collection for a prolonged period.  Interactions between 
animal handlers and small rodents have been shown to induce a stress response in small 
rodents (104) which could artificially alter sex steroid levels in the bloodstream.  Steps 
were taken to minimize the significant stress on the animals in this study for humane 
purposes and to limit the potential to induce aberrant sex steroid concentrations.  During 
blood sampling, animals were handled using controlled and secure techniques, monitored 
for signs of elevated stress (vocalizations, biting, increased mobility, etc.), and directly 
exposed to technicians for a minimal amount of time.  Most blood draws from initial 
immobilization to release back into the home cage were less than 10 minutes. 
 Exemestane is an irreversible aromatase inhibiting drug and it is expected that 
administration of this pharmacological substance should lead to a decrease in estrogen 
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content, but effect testosterone levels very little.  Surprisingly, we showed that the 
concentrations of both steroids are highly variable in the presence of the drug.  Sex 
steroid levels in exemestane treated animals have not been quantified by others (44, 61) 
and therefore, the source of the variability in hormone concentrations are difficult to 
identify.  In addition to its inhibitory effects, exemestane has been shown to possess 
androgenic characteristics in clinical situations including an affinity to bind the androgen 
receptor (62).  The dosage used in this project was previously shown to have 
physiological effects on bone characters and tumor morphology, effects that could have 
been due to the androgenic rather than the aromatase inhibitory nature of exemestane.  In 
order to parse the androgenicity and aromatase inhibitory effects of the drug, the results 
from the first experiment were repeated using letrozole, a reversible aromatase inhibitor 
that does not have androgenic effects.  In this repeated experiment, very similar results 
were observed indicating that the aromatase inhibiting effects of the drugs did not alter 
wheel running behavior and that physical activity regulation via estrogenic sources was 
not an absolute requirement in our model. 
 Conclusions:  The present study evaluated the effects of two aromatase inhibitors 
on wheel running activity in male C57BL/6J mice.  Neither aromatase inhibitor altered 
wheel running activity in intact or orchidectomized animals.  These data, in conjunction 
with wheel running measures in aromatase knockout mice (49) and vinclozolin treated 
mice (29), suggests that aromatization of testosterone is not needed for activity regulation 
as has been earlier postulated (114) and that a direct androgenic mechanism regulates 
activity levels in mice.  The complexity of such regulatory mechanisms and the low 
number of available research studies provide ample basis for reinvigoration of this 
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research area.  In particular, studies that partition the androgenic and aromatase inhibitory 
effects of the irreversible aromatase inhibitors will provide valuable insight into this 
mechanism.  Future research should also utilize pharmacological and chemical methods 
to manipulate the function of the aromatase complex and androgen receptors of intact and 
gonadectomized mice while monitoring wheel running.  Physical inactivity has reached 
epidemic proportions in the developed world leading to increasing rates of obesity and 
hypokinetic diseases, thus identifying and understanding the biological mechanisms that 
regulate activity levels can profoundly influence human health worldwide. 
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Figure 12.  The experimental timelines (days) for assessing physical activity levels in 
aromatase inhibited and sex steroid modified mice.  Black bars represent recovery 
periods—after surgeries and after cessation of injections—in which running wheels were 
not in the cages. 
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Figure 13.  Wheel running indices (distance, duration, and speed) for male C57BL/6J 
mice at baseline, during injections, and during post-injection clearance.  White bars 
denote control mice (n=10) that received vehicle injections and black bars denote 
experimentally treated mice (n=10) that received exemestane injections. 
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Figure 14.  Wheel running indices (distance, duration, and speed) for male C57BL/6J 
mice at baseline, during injections, and during injections supplemented with either 
testosterone or 17β-estradiol.  White bars denote control mice (n=10) that received 
vehicle injections and blank silastic implants.  Checkered bars denote experimentally 
treated mice (n=10) that received exemestane injections and silastic implants containing 
testosterone.  Black bars denote experimentally treated mice (n=10) that received 
exemestane injections and silastic implants containing 17β-estradiol. 
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Figure 15.  Wheel running indices (distance, duration, and speed) for male C57BL/6J 
mice at baseline, during injections, during steroid replacement, and during steroid 
replacement with injections.  White bars denote control mice (n=10) that received vehicle 
injections and blank silastic implants.  Checkered bars denote experimentally treated 
mice (n=10) that received silastic implants containing testosterone and exemestane 
injections.  Black bars denote experimentally treated mice (n=10) that received silastic 
implants containing 17β-estradiol and exemestane injections.  *=significantly different 
from controls and baseline values. 
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Figure 16.  Wheel running distance in C57BL/6J mice at baseline, after injection of 
letrozole (reversible aromatase inhibitor), and during a seven day drug clearance period.  
The white bars represent the control mice (n=10) and black bars represent the 
experimental mice (n=10). 
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Table 5.  Sera/Plasma testosterone and 17β-estradiol concentrations from 
mice* at baseline and under various placebo and experimental conditions 
Condition (n=T/E2) Testosterone (ng·ml-1) 
mean±SD 
17β-Estradiol (pg·ml-1) 
mean±SD 
Baseline (n=3/3) 6.32±2.79 59.82±16.72 
Placebo (n=15/15) 11.53±7.54 397.08±881.50 
Experimental 
EXEM (n=2/1) 9.97±1.82 472.82 
EXEM Clearance (n=2/1) 13.92±9.89 57.31 
EXEM+T (n=2/1) 15.69±7.54 660.26 
EXEM+E2 (n=2/2) min 121.07±21.90 
ORCH (n=3/2) min 109.79±29.71 
ORCH+T (n=3/2) 15.37±1.21 151.96±53.20 
ORCH+E2 (n=2/3) 0.21±0.23 613.44±185.90 
ORCH+T+EXEM (n=2/2) 14.08±1.34 346.55±116.04 
ORCH+E2+EXEM (n=2/2) 11.70±9.55 680.91±262.98 
*Sera/Plasma from 3 mice were pooled 
Abbreviations: EXEM=Exemestane Injections, T=Testosterone, E2=17β-
Estradiol, ORCH=Orchidectomy,  min=at the minimum of prediction curve 
 
CHAPTER 4: 
THE SEX STEROIDS DO NOT INFLUENCE PHYSICAL ACTIVITY LEVELS 
THROUGH THE DOPAMINE 1 RECEPTOR 
 
 
Abstract 
 Physical activity levels are highly associated with lower occurrences of chronic 
disease and disability; therefore, increased physical activity may provide substantial 
benefit to the individual and society.  Previous literature has suggested that testosterone 
and dopaminergic functioning may interact to affect physical activity.  Thus, the purpose 
of this project was to investigate the effects of testosterone and D1-like antagonism on 
the physical activity levels of orchidectomized mice.  Thirty C57BL/6J mice were used in 
this project.  At the onset, 20 mice were orchidectomized and ten received sham 
surgeries.  Wheel running was monitored for seven days after a post-surgery recovery 
period.  Next, testosterone and a D1-like antagonist were administered to the 
orchidectomized mice (n=10 per group) and wheel running was monitored for seven 
more days.  At the end of experiment, the nucleus acumbens and striatum were assessed 
for dopamine 1 receptor (Drd1) mRNA expression.  The experimental treatment affected 
all three wheel running indices (p=0.0001).  The orchidectomized mice ran less than 
controls and testosterone replacement increased wheel running to control levels.  The D1-
like antagonist did not recover wheel running back to control levels.  End of experiment 
Drd1 mRNA expression did not differ between the experimental conditions (p=0.83).  In 
conclusion, though it appears that testosterone regulates activity levels in
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mice, the effect is not related to the availability of Drd1 genetic transcripts. 
Introduction 
 Increasing physical activity levels is an important health related goal for the 
developed world and has been shown to reduce the risks associated with cardiovascular 
disease (33, 148), various types of cancer (132), diabetes (148), and obesity (150).  
Mokdad et al. (87) found physical inactivity and poor diet were major actual causes of 
death (approximately 15.2%) in the United States and was the second highest actual 
cause of death behind tobacco use (approximately 18.1%).  In addition, the trend toward 
inactivity is increasing and is expected to become the leading cause of actual death in a 
few years (87).  This trend toward inactivity and chronic disease persists despite a 25+ 
year foundation of research focused on environmental regulators of activity in adults 
(147) and adolescents (27).  This adverse trend may occur for at least two reasons; the 
translational application of scientific research is inefficient or there are more powerful 
activity influences overriding the inputs of the environmental factors.  Certainly, the 
former is a barrier experienced by all types of scientific discoveries and may be resolved 
through fervent application of public heath policy, alteration of urban development 
trends, or modification of socioeconomic perception; however, the latter has recently 
received more attention from the scientific community resulting in several remarkable 
findings. 
 Several studies have indicated important genetic and biologic pressures 
influencing activity and exercise traits in both humans (64, 76, 130, 131, 137) and rodents 
(28, 43, 70, 77, 79, 82, 83, 136, 139, 145).  In particular, testosterone and 17β-estradiol 
have been shown to significantly modify wheel running in rodents (see ref. 81 for a brief 
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review).  The surgical removal of the gonads in either sex results in a consistent reduction 
of activity levels that is recovered to various extents upon reintroduction of testosterone 
or 17β-estradiol (13, 14, 19, 43, 90, 96, 99).  Currently, the mechanistic effectors 
transmitting the sex steroids’ effects have not been substantially identified, but the effect 
appears to be centrally regulated (18, 53, 66, 68, 70, 139). 
 Several areas in the brain and factors acting within these areas have been 
suggested to influence activity levels in rodents.  Kennedy (66) induced inactivity via 
ovariectomy in rats and observed increased activity after administration of estrogens.  
The recovery abilities of the estrogens were inhibited in rats with lesions to the 
ventrolateral hypothalamus (66).  Colvin and Sawyer (18) observed increased wheel 
running in rats receiving estrogens directly to the medial forebrain bundle, but found no 
evidence that the ventrolateral hypothalamus was involved in regulation of activity.  Hitt 
and Gerall (53) implanted electrodes directly into 14 distinct regions of the brain and 
observed reduced wheel running during stimulation of central hypothalamus structures; 
stimulation of the posterior and anterior regions of the hypothalamus did not effectuate 
similar results.  The authors speculated that the electrical stimulation blocked estrogen’s 
ability to interact with neurons in the central hypothalamus resulting in lower activity 
levels (53).  Fahrbach et al. (26) confirmed the work of Hitt and Gerall (53) with direct 
implantation of estradiol to various structures in the anterior hypothalamus and pre-optic 
areas, but also noted variable responsiveness to the implants.  More recently, Knab et al. 
(70) and Verhagen et al. (139) noted variations in activity patterns that associated with 
low dopamine 1 receptor (Drd1) mRNA expression levels and dopamine/serotonin 
release in the nucleus acumbens respectively.  The dopamine system of the nucleus 
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acumbens and striatum in rodents also shows a significant sexual dimorphism, an effect 
that may occur through G-protein-coupled receptors and may be stimulated by 
interactions with the sex steroids—directly through estrogens or indirectly through the 
aromatic conversion of testosterone (9).  Moreover, Hill et al. (50) observed an apoptotic 
reduction in dopaminergic neurons in estrogen-deficient aromatase knockout mice. 
 While dopaminergic neurons have been shown to be responsive to changes in sex 
steroid levels, no studies have investigated the interaction between testosterone and 
dopamine receptors to determine if there is an interactive effect on activity levels.  
Therefore, the purpose of this paper was to evaluate the changes to Drd1 mRNA 
expression levels in orchidectomized mice after administration of testosterone or a D1-
like antagonist.  In addition, the activity levels were evaluated in orchidectomized mice 
receiving testosterone or a D1-like antagonist.  We hypothesized that Drd1 levels would 
not differ from the levels observed in control mice resulting in wheel running levels that 
were comparable to the levels observed in the non-orchidectomized control animals. 
Methods 
 Animals:  This project utilized 30 male C57BL/6J mice (Jackson Laboratory, Bar 
Harbor, ME), which were divided into three experimental groups (Control, ORCH 1, 
ORCH 2).  Upon arrival at the animal housing facility the mice were group housed seven 
or eight per cage.  The mice were randomly assigned to individual cages at nine weeks of 
age and were allowed ad libitum access to water and food (Harlan Teklad, Madison, WI).  
All animal use conformed to ethical standards set by the scientific community and was 
approved by the UNC Charlotte Institutional Animal Care and Use Committee. 
 Protocol Overview:  Double orchidectomies were performed two days after 
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individually housing the mice.  The control animals (n=10) received sham procedures and 
the two experimental groups (n=10 per group) received real orchidectomies.  These 
surgeries were followed by a 10-day recovery period.  In brief, all animals received a pre-
emptive dose of carprofen (5mg·kg-1).  All surgeries were performed under 2% isoflurane 
anesthesia mixed with oxygen at a flow rate of 600 ml·min-1.  A small incision was made 
on the midline of the scrotal sac just inferior to the penis after the area was sterilized with 
betadine and 70% alcohol scrubs.  Each testicle was exposed and removed along with the 
epididymis.  The surgical wound was closed with a sterile surgical wound clip.  The sham 
procedures were identical to the real procedures, but the testicles and epididymis were 
left intact.  All procedures were performed by an experienced technician. 
 At the end of the post-operative 10-day recovery period, metal running wheels 
(Ware Manufacturing, Phoenix, AZ) were installed in each cage.  The wheels had a 40 
mm running surface, 450 mm circumference, and were equipped with bicycle computers 
(BC500, Sigma Sport, Olney, IL) specifically calibrated to measure running distance 
(km) and duration (min).  Speed was calculated from these variables (m·min-1).  The 
running wheel data were collected every 24 hours and averaged over seven days.  Wheel 
resistance was checked daily and the axles were lubricated with oil as needed.  The data 
from maladjusted wheels or improperly functioning computers were eliminated from that 
dataset on the day the error was noted. 
 The mice were allowed two days to acclimate following introduction of the 
wheels.  For the following seven days, post-surgery wheel running indices were assessed.  
After this first seven day period, silastic (Dow Corning, Midland, MI) capsules (17) were 
implanted into the control and ORCH 1 groups.  The control animals received empty 
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capsules and experimental animals received testosterone (Sigma-Aldrich, St. Louis, MO) 
filled capsules.  The capsules were 10 mm long and had an internal diameter of 1.02 mm.  
The ends of the implants were sealed with silicone glue.  A small incision was made in 
the skin on the lateral aspect of the neck and a pocket was created between the skin and 
the fascia to contain the implant.  All procedures were performed under the same 
conditions as the orchidectomy surgeries, except that no pre-emptive analgesic was 
necessary for this procedure. 
 The mice were allowed two days to recover from the surgical wounds prior to 
reevaluating wheel running.  At the onset of this period, the second experimental group 
(ORCH 2) received daily injections of a D1-like antagonist (SCH23390; Tocris 
Bioscience, Ellisville, MO), in sterile saline (0.3 ml) at a concentration of 0.10 mg·kg-1 as 
an intraperitoneal injection on the animal’s right side.  Each preparation was filtered 
through a 0.2 micron cellulose filters prior to injection.  Control mice received 0.3 ml 
sterile saline injections. 
 At the end of the study, all mice were euthanized and the brains were prepared for 
further analysis.  Specifically, the nucleus acumbens and striatum regions (NA/S) of the 
brain were analyzed for dopamine 1 receptor sub-form A (Drd1) mRNA expression 
levels.  Quantitative real time polymerase chain reaction (qRT-PCR) experiments were 
completed to estimate the levels of Drd1 expression as previously described (41).  Total 
RNA was extracted from the right portion of the NA/S using the Trizol method (TRI 
Reagent, Sigma-Aldrich, St. Louis, MO) per the manufacturer’s specifications.  Total 
RNA was reverse transcribed to cDNA via a QuantiTect Reverse Transcription Kit 
(Qiagen, Germantown, MD).  The quantity of cDNA was assessed via 
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spectrophotometery (NanoDrop, Wilmington, DE). 
 Drd1 specific primers (forward: ttctcctttcgcatcctcac, reverse: 
tgtcgaaacctgatgacagc) were designed in Primer 3 (Whitehead Institute for Biomedical 
Research, Cambridge, MA) and manufactured (Integrated DNA Technologies, San 
Diego, CA) to flank an intron region.  Real Time PCR experiments were completed using 
an ABI 7500 Fast Real Time PCR System (Applied Biosystems, Carlsbad, CA).  The 
Drd1 mRNA expression levels were assessed relative to β-actin.  The β-actin primers 
(forward: agacttcgagcaggagatgg, reverse: aaggaaggctggaaaagagc) were designed and 
manufactured similar to the Drd1 primers.  Samples were analyzed in triplicate and the 
two nearest data points per sample were operationally defined as the true crosspoint value 
for that sample and were used in a modified version of the Pfaffl (98) method to calculate 
relative expression levels of Drd1 mRNA.  The efficiency values (E) were determined, as 
previously described (98), from the slope of a log-linear dilution curve (input 
concentrations=1:1, 1:10, 1:100, 1:1000) and the expression ratios calculated using the 
following equation: 
 
where E=efficiency of the PCR reaction for the target and reference genes, and CP=the 
crosspoint thresholds of the target and reference genes. 
 Blood Sampling and ELISA Analyses:  The current project was completed in 
conjunction with two other related projects.  Blood was sampled from all mice in these 
projects and pooled based on the experimental condition at the time of blood sampling.  
For this project, blood samples were acquired prior to the gonadectomy surgery, 14 days 
after the surgery, and at the end of the study.  Blood samples were collected in microvette 
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capillary tubes from the saphenous veins in conscious mice or were collected directly 
from the inferior vena cava at the end of the experiment.  The sera/plasma was separated 
from the red cell mass via centrifugation.  All samples were stored at −80°C until steroid 
quantification via enzyme-linked immunosorbent assays (ELISA) could be performed.  
Three samples from each experimental and control group were assayed for testosterone 
and 17β-estradiol (IBL-America, Inc., Minneapolis, MN) across the three time points.  A 
steroid extraction procedure (ethyl acetate extraction) was used prior to running each 
assay.  Optical absorbance was measured in duplicate for each sample and calibrator 
solution.  The concentrations of unknown values were predicted based on the calibrators’ 
optical absorbance and known concentration.  The duplicate measures were averaged to 
represent the actual concentration value from each sample. 
 Statistical Analysis:  Three (control, ORCH1, ORCH2) by two (post-surgery and 
post-replacement) analysis of variance (ANOVA) tests were used to compare differences 
in wheel running activity and Drd1 mRNA expression.  Tukey’s HSD post-hoc tests were 
used to assess individual differences when a main effect or an interaction was present.  
An a priori alpha level of 0.05 was considered significant. 
Results 
 The results for wheel running are shown in Figure 17.  All three wheel running 
indices changed in response to the experimental treatments applied to this cohort of mice 
(p=0.0001).  Wheel running distance, duration, and speed were lower in the 
orchidectomized mice than in the placebo animals.  Testosterone administration 
recovered the orchidectomy-induced wheel running deficit in all indices.  Distance and 
duration remained significantly lower with the D1-like antagonist than the levels 
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observed in both the placebo and testosterone treated animals; however, speed was 
increased in this group to the levels observed in the placebo animals immediately 
following sham surgical orchidectomies.  The observed speed increase in the D1-like 
antagonized mice, however, remained lower than the speed levels observed in the 
testosterone treated animals and the control animals during the interventional stage of the 
experiment. 
 The relative mRNA expression of the dopamine 1 receptor in the nucleus 
acumbens and striatum was not statistically different (p=0.83) between groups at the end 
of the study (Figure 18).  The average relative Drd1 mRNA expression levels (% of β-
actin) for placebo (mean=0.80, SD=0.29), testosterone (mean=0.72, SD=0.38), and D1-
antagonist (mean=0.72, SD=0.34) were homogenously distributed across the entire 
sample population despite the significant differences in wheel running activity.  
Furthermore, the wheel running indices did not correlate (distance: r=0.042, duration: 
r=0.077, speed: r=-0.102) with relative Drd1 mRNA expression levels. 
 Testosterone and 17β-estradiol concentrations are listed in Table 6.  Statistically 
the groups did not exhibit significantly different concentrations for either steroid; 
however, the steroid concentration amongst the control and experimental groups were 
physiologically distinct. 
Discussion 
 Castration or orchidectomy has been shown to be a robust inhibitor of wheel 
running vigor in the male rodents (20, 34, 35, 54-56, 99, 106).  A similar effect was 
observed in the current study in which male C57BL/6J mice ran very little after 
orchidectomy surgery compared to reproductively intact control animals.  Sex steroid 
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administration in various forms has been shown to reverse the gonadectomy-induced 
wheel running deficit in both male and female rodents (20, 43, 54, 55, 60, 99, 141, 144).  
In the current study, testosterone administration via silastic implants resulted is recovery 
rates—equal to the levels of control mice—which is similar to the levels reported by 
others for estrogens (43) and testosterone (99).  The D1-like antagonist failed to increase 
wheel running to the level observed in controls.  Drd1 mRNA levels were similar 
between the experimental and control groups despite the noted differences in activity 
levels, thus the hypothesized interaction between testosterone and dopaminergic activity 
resulting in higher levels of activity was unfounded. 
 Sex Steroids, Dopamine and Activity:  The modulation of steroid levels via 
surgical procedures and replacement strategies is speculated to affect morphology and 
function in specific parts of the brain (81).  Several authors have investigated these 
potential alterations through direct and indirect manipulation of neurological circuits in 
various areas of the brain.  Consequently, most of the direct manipulation studies have 
been completed in female rats and have utilized various estrogens (26, 53, 66, 68).  The 
current project is novel in that it evaluated the effects of a primarily androgenic sex 
steroid noting large increases in wheel running after testosterone administration without 
changes to Drd1 mRNA in the nucleus acumbens and striatum.  This observation 
suggests that no interactions between Drd1 and the sex steroids were necessary to 
manipulate the activity response in male mice; however, several past studies suggest that 
Drd1 function and/or quantity are vitally important in the regulation of activity levels in 
rodents.  Our findings suggest that the sex steroids and dopamine system modulate 
physical activity through separate physiological pathways.  This interpretation is 
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complicated by the fact that in our mice the aromatase complex was fully functional; 
therefore, we can assume that some estrogen was present after conversion by the 
aromatase complex.  However, we have shown that presence of a functioning aromatase 
complex does not affect activity; therefore, the presence of estrogens should not 
confound our interpretation. 
 Rhodes et al. (103) evaluated several neurological modulating compounds in mice 
artificially selected for high wheel running.  In particular, blockade of Drd1 via 
SCH23390—the D1-like antagonist used in the present study—resulted in reduced wheel 
running in control lines and high activity selected lines; however, the magnitude of the 
decrease was much less in the high activity mice.  The authors concluded that D1-like 
receptors were expressed much less in the high activity line, and thus, showed a lower 
sensitivity and response to the antagonist (103).  Supporting Rhodes et al.’s (103) 
suggestion of dopaminergic involvement, Knab et al. (70) evaluated mRNA expression 
levels of several dopamine genes in low (C3H/HeJ) and high (C57L/J) activity inbred 
mice and found that Drd1and tyrosine hydroxylase mRNA were expressed at lower levels 
in the high active mice (70). 
 Recently, dopamine and serotonin levels were evaluated in a mouse model of 
activity-based anorexia during food-anticipatory activity and feeding (139).  The levels of 
both neurotransmitters were elevated during feeding but remained low during the food 
anticipatory behavior portion of the study—when the mice were most active.  It is 
noteworthy that the associative relationship regarding general dopaminergic functionality 
noted by Knab et al. (70) was similarly repeated in the data of Verhagen et al. (139) in the 
nucleus acumbens.  The current project, on the contrary, did not demonstrate this 
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relationship after reintroducing testosterone. 
 Sex Steroids and Central Control of Activity:  The brain is highly permeable and 
responsive to changes in sex steroid levels (94).  Furthermore, changes to the anterior 
hypothalamus, medial pre-optic area, nucleus acumbens, and striatum have been shown 
to associate with activity levels in various kinds/strains of mice (53, 66, 68, 70, 103, 139).  
Taken in concert, the sex steroids are realistic intermediaries between physiological 
function and phenotypic expression of activity levels in rodents.  The current project 
demonstrated high levels of activity in steroid treated mice that did not associate with 
Drd1 mRNA expression levels in the nucleus acumbens and striatum.  At a minimum, 
this suggests that Drd1 transcription in the nucleus acumbens and striatum is unaffected 
by changes in sex steroid levels and were not involved in regulating activity levels in the 
current cohort of mice. 
 It has been suggested that biologically regulated activity levels are most likely 
centrally controlled (113); therefore, though the dopamine 1 receptors in the nucleus 
acumbens and striatum appeared uninvolved in regulating activity levels in the current 
project, other receptors and brain regions may be of greater consequence in considering 
the role of sex steroids in physical activity.  The hypothalamus and medial pre-optic area 
have been the targets of several studies in which portions of the brain have been directly 
exposed to sex steroids—estrogens in particular.  Lesions to the ventrolateral aspect of 
the hypothalamus resulted in low activity levels that were unresponsive to estrogen 
administration (66, 68).  Hitt and Gerall (53) noted a higher propensity for rats to be 
active during the estrogen peak if the hypothalamus and pre-optic areas were 
unencumbered.  The function of these brain areas were not investigated in the current 
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cohort of C57BL/6J mice and are potential future targets of investigations into activity 
regulation. 
 Study Limitations:  The current project evaluated activity levels in D1-like 
antagonized mice with orchidectomy-induced physical inactivity and though the D1-like 
antagonists have been shown to decrease activity levels in some mice (103), the current 
cohort of mice appeared unaffected by the drug.  The numerous differences in the 
aforementioned literature—the current project included—indicate that the effect of the 
dopaminergic system on activity is far from consistent.  Given the dissimilarities, 
interpretation and mechanism identification is likely strain specific and requires extreme 
caution. 
 The injection protocol used in the current project was developed based on past 
literature (103); however, several other studies have utilized cannula systems or 
electrodes to apply compounds or stimuli directly to specific brain regions.  These types 
of systems have primarily been used to directly administer sex steroids to the 
hypothalamus (53, 66, 68).  Application of these direct manipulation systems to the 
nucleus acumbens or striatum may induce different results than we observed by avoiding 
issues related to inadequate drug delivery to the brain or premature drug clearance via the 
liver or kidneys. 
 The results of this study are limited to male mice, and thus, extension of the 
current data to female populations are uncertain.  Though untested in the current project, 
the genetic and biological mechanism relating to central regulation of physical activity 
could have sex specificity.  In fact, physical activity displays a significant sexual 
dimorphism in all three wheel running indices: distance, duration, and speed (52, 82). 
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However, we have observed that in spite of differing baseline activity levels, both sexes 
responded in a similar manner to supplements of testosterone and estrogen suggesting 
that the sexual dimorphism may effect baseline activity values and not the amount of 
alteration in activity induced by supplements. 
 Conclusions:   The present study evaluated the effects testosterone and a D1-like 
antagonist (SCH23390) on physical activity patterns in male orchidectomized C57BL/6J 
mice.  Wheel running indices were low in the orchidectomized animals, but were 
increased with administration of testosterone.  Blocking the Drd1 receptors did not affect 
physical activity levels in orchidectomized mice and the Drd1 mRNA levels in control, 
testosterone-treated, and D1-like antagonized animals were not different.  Therefore, our 
data do not support an interaction between the sex steroids and Drd1 levels in activity 
regulation in C57BL/6J male mice.  Future research will focus on evaluating the sex 
steroids’ effects on other brain regions and neurotransmitter systems in the context of 
physical activity regulation. 
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Figure 17.  Wheel running indices for C57BL/6J mice after sham or surgical 
orchidectomy and administration of control implants, testosterone implants, or D1-like 
antagonist (daily injections).  White bars=daily average wheel running after surgery; 
black bars=daily average wheel running with interventional strategies.  *=significantly 
different from placebo mice and testosterone treated orchidectomized mice. 
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Figure 18.  End of experiment relative mRNA expression levels for dopamine 1 receptors 
in the nucleus acumbens and striatum of placebo, testosterone, and D1-like antagonist 
treated male C57BL/6J mice. 
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Table 6.  Sera/Plasma testosterone and 17β-estradiol concentrations for mice* at 
baseline and under various placebo and experiment conditions 
Condition (n=T/E2) Testosterone (ng·ml-1) 
mean±SD 
17β-Estradiol (pg·ml-1) 
mean±SD 
Baseline (n=3/3) 6.32±2.78 59.82±16.72 
Placebo (n=15/15) 11.53±7.54 397.08±881.50 
Experimental 
ORCH (n=3/2) min 109.79±29.71 
ORCH+SCH23390 (n=2/1) 4.85±7.20 291.09 
ORCH+T (n=3/2) 15.37±1.21 151.96±53.20 
*Sera/Plasma from 3 mice were pooled 
Abbreviations: ORCH=Orchidectomy, T=Testosterone Implant, min=at the 
minimum of prediction curve 
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SUMMARY 
 
 
 Physical activity levels inversely correlate with risks for obesity, certain cancers, 
diabetes, hypertension, and other hypokinetic diseases.  The understanding of how 
activity levels are regulated, thus, remains an important health related goal.  The sex 
steroids—given their ability to alter activity levels in rodents—are potent biological 
regulators of physical activity levels. 
 The projects described in this dissertation evaluated the effects the sex steroids 
have on physical activity regulation.  Physical activity levels in rodents were measured 
via running wheels under various sex steroid modulated physiological conditions.  I 
observed that the removal of endogenous sex steroid producing tissues resulted in greatly 
depressed wheel running in both male and female mice.  Replacement of testosterone or 
17β-estradiol reversed the gonadectomy induced wheel running deficit in both sexes, with 
testosterone replacement recovering pre-surgery activity levels in all mice. 
 It has been suggested that sex steroid alterations to wheel running occur through 
estrogenic pathways.  However, I found that inhibition of the aromatase complex—the 
enzyme involved in primary production of estrogens via testosterone in male mice—did 
not result is significant changes to wheel running.  These results indicate that an 
“estrogen-only” dogma of sex steroid activity regulation is likely inaccurate.  Our results 
strongly suggest that androgenic pathways regulating activity exist and strongly influence 
physical activity levels in rodents. 
 Current literature suggests that an organism’s general level of physical activity 
may be regulated by the nucleus acumbens in the brain, and in particular, by dopamine 1 
receptors.  Other literature has implicated a complex interaction between sex steroids and 
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the dopamine system, thus suggesting that this interaction may be altered with changes in 
sex steroid levels.  When I reintroduced testosterone to orchidectomized mice, they 
recovered wheel running to normal levels, but they did not show altered dopamine 1 
receptor mRNA in the nucleus acumbens or striatum.  Furthermore, administration of a 
D1-like antagonist to orchidectomized mice did not reinvigorate activity suggesting that 
testosterone’s abilities to alter activity are not propagated through this receptor. 
 In this set of dissertation studies, I have provided evidence that the sex steroids 
regulate activity levels in mice through independent androgenic and estrogenic pathways.  
The androgenic affects do not appear to occur through the dopamine 1 receptor in the 
nucleus acumbens and striatum.  In conclusion, the sex steroids are potential targets for 
therapeutic strategies aimed to enhance population wide activity patterns leading to 
overall health benefits, reduced utilization of the health care system, and improved 
quality of life.
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